Form DEF 14A - Other definitive proxy statements

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

SCHEDULE 14A

(RULE 14a-101)

SCHEDULE 14A INFORMATION

PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES

EXCHANGE ACT OF 1934

Filed by the Registrant ý

Filed by a Party other than the Registrant ¨

Check the appropriate box:


¨	Preliminary Proxy Statement
¨	Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
ý	Definitive Proxy Statement
¨	Definitive Additional Materials
¨	Soliciting Material Pursuant to Section 240.14a-12


Barings BDC, Inc.
(Name of Registrant as Specified in its Charter)

(Name of Person(s) Filing Proxy Statement if Other Than the Registrant)
Payment of Filing Fee (Check the appropriate box):
ý		No fee required.
¨		Fee paid previously with preliminary materials.
¨		Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

300 South Tryon Street, Suite 2500

Charlotte, North Carolina 28202

(704) 805-7200

March 11, 2025

Dear Stockholder:

You are cordially invited to the 2025 Annual Meeting of Stockholders of Barings BDC, Inc., to be held

virtually on Thursday, May 8, 2025 at 8:30 a.m. (Eastern Time), at the following website:

www.virtualshareholdermeeting.com/BBDC2025.

The notice of Annual Meeting of Stockholders and proxy statement accompanying this letter provide an

outline of the business to be conducted at the meeting.

It is important that your shares be represented at the Annual Meeting. If you are unable to attend the meeting

virtually, I urge you to vote your shares by completing, dating and signing the enclosed proxy card and promptly

returning it in the envelope provided. If a broker or other nominee holds your shares in “street name,” your broker

has enclosed a voting instruction form, which you should use to vote those shares. The voting instruction form

indicates whether you have the option to vote those shares by telephone or by using the Internet. Your vote is

important.

Sincerely yours,

Eric Lloyd

Chief Executive Officer

& Executive Chairman

BARINGS BDC, INC.

300 South Tryon Street, Suite 2500

Charlotte, North Carolina 28202

(704) 805-7200

NOTICE OF ANNUAL MEETING OF STOCKHOLDERS

To Be Held On Thursday, May 8, 2025

To the Stockholders of Barings BDC, Inc.:

The 2025 Annual Meeting of Stockholders (the “Annual Meeting”) of Barings BDC, Inc. (the “Company”)

will be held virtually on Thursday, May 8, 2025 at 8:30 a.m. (Eastern Time) at the following website:

www.virtualshareholdermeeting.com/BBDC2025. The Annual Meeting will be held in a virtual meeting format

only. You will not be able to attend the Annual Meeting in person.

You are being asked to consider and vote upon the following proposals:

1. To elect three Class I directors to serve for a three-year term and until their successors have been duly

elected and qualify (Proposal No. 1);

2. To approve a proposal to authorize the Company, pursuant to subsequent approval of its Board of

Directors, to issue and sell shares of its common stock (during the 12 months following such authorization) at a price

below the Company’s then-current net asset value per share in one or more offerings, subject to certain limitations

set forth in the Proxy Statement accompanying this Notice (including, without limitation, that the number of shares

issued and sold pursuant to such authority does not exceed 30% of the Company’s then-outstanding common stock

immediately prior to each such offering) (Proposal No. 2); and

3. To transact such other business as may properly come before the meeting.

We have enclosed our annual report on Form 10-K for the year ended December 31, 2024, proxy statement

and a proxy card.

Our Board of Directors has fixed the close of business on March 7, 2025, as the record date for the

determination of stockholders entitled to notice of and to vote at the Annual Meeting and at any adjournment or

postponement thereof. We intend to mail these materials on or about March 11, 2025, to all stockholders of record

entitled to vote at the Annual Meeting.

Each Company stockholder is invited to attend the Annual Meeting virtually. You or your proxyholder will be

able to attend the Annual Meeting online, vote and submit questions by visiting

www.virtualshareholdermeeting.com/BBDC2025 and using a control number assigned by Broadridge Financial

Solutions, Inc. (“Broadridge”). Please see "How To Participate in the Annual Meeting" in the accompanying proxy

statement for more information.

Whether or not you expect to be present at the virtual Annual Meeting, please sign the enclosed proxy card

and return it promptly in the self-addressed envelope provided. Instructions are shown on the proxy card. If a broker

or other nominee holds your shares in “street name,” that is they are registered in the name of your broker, bank,

trustee or other nominee, you should have received a notice containing voting instructions from your nominee rather

than from us. You should follow the voting instructions in the notice to ensure that your vote is counted. The voting

instruction form indicates whether you have the option to vote those shares by telephone or by using the Internet.

Your vote is extremely important to the Company. In the event there are not sufficient votes for a quorum or

to approve or ratify any of the foregoing proposals at the time of the Annual Meeting, the Annual Meeting may be

adjourned in order to permit further solicitation of proxies by the Company.

OUR BOARD OF DIRECTORS INCLUDING EACH OF THE INDEPENDENT DIRECTORS,

UNANIMOUSLY RECOMMENDS THAT YOU VOTE "FOR" EACH OF THE PROPOSALS.

If you have additional questions and you are a Barings BDC, Inc., stockholder you may contact the

Company’s Investor Relations department at 1-888-401-1088, or by email at BDCinvestorrelations@barings.com.

You may also contact Broadridge, the Company's proxy solicitor, toll-free at 1-877-777-4652 for directions on how

to attend the Annual Meeting virtually and how to vote during the virtual meeting.

By order of the Board of Directors,

Alexandra Pacini

Secretary, Barings BDC, Inc.

Charlotte, North Carolina

March 11, 2025

This is an important Annual Meeting. To ensure proper representation at the Annual Meeting, please

complete, sign, date and return the proxy card in the enclosed, self-addressed envelope, or vote your shares

electronically via the Internet or by telephone. Please see the enclosed proxy statement and the enclosed proxy

card for details about electronic voting. Even if you vote your shares prior to this Annual Meeting, you still

may attend the meeting and vote your shares electronically via the live webcast if you wish to change your

vote.

Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting of Stockholders to

Be Held on Thursday, May 8, 2025:

Our notice of the Annual Meeting, proxy statement, and annual report on Form 10-K for the year ended

December 31, 2024 are available on the Internet at https://materials.proxyvote.com/06759L.

The following information applicable to the Annual Meeting may be found in the notice of the Annual Meeting,

proxy statement and accompanying proxy card:

▪The date, time and location of the meeting;

▪A list of the matters intended to be acted on and our Board of Directors' recommendations regarding those

matters;

▪Any control/identification numbers that you need to access your proxy card; and

▪Information on how to obtain directions to attend the Annual Meeting electronically via the live webcast.

BARINGS BDC, INC.

300 South Tryon Street, Suite 2500

Charlotte, North Carolina 28202

(704) 805-7200

PROXY STATEMENT

2025 Annual Meeting of Stockholders

This proxy statement is furnished in connection with the solicitation of proxies by the Board of Directors (the

“Board of Directors” or the “Board”) of Barings BDC, Inc. (the “Company,” “Barings BDC,” “we,” “us” or “our”)

for use at our 2025 Annual Meeting of Stockholders to be held virtually on Thursday, May 8, 2025 at 8:30 a.m.

(Eastern Time) at the following website: www.virtualshareholdermeeting.com/BBDC2025, and at any postponement

or adjournment thereof (the “Annual Meeting”). The Notice of Annual Meeting, this proxy statement, the

accompanying proxy card and our Annual Report for the fiscal year ended December 31, 2024, which includes

audited financial statements for the year ended December 31, 2024, are first being released on or about March 11,

2025 to the Company's stockholders of record as of the close of business on March 7, 2025.

We encourage you to access the Annual Meeting prior to the start time. The live webcast will begin promptly at 8:30

a.m. (Eastern Time) on Thursday, May 8, 2025. We will have technicians ready to assist you with any technical

difficulties you may have accessing the live webcast. Technical support will be available on the meeting website

starting approximately 8:15 a.m. (Eastern Time) and will remain available until the Annual Meeting has finished.

The virtual meeting platform is fully supported across browsers and devices running the most updated version of

applicable software and plugins. Participants should ensure that they have a strong WiFi connection if they intend to

participate in the Annual Meeting. Participants should also give themselves plenty of time to log in and ensure that

they can hear audio prior to the start of the Annual Meeting. Please see “How to Participate in the Annual Meeting”

below for additional details.

We encourage you to vote your shares, either by voting electronically via the live webcast of the Annual Meeting or

by granting a proxy (i.e., authorizing someone to vote your shares). If you properly sign, date and mail the

accompanying proxy card or authorize your proxy by telephone or through the Internet, and the Company receives it

in time for voting at the Annual Meeting, the persons named as proxies will vote your shares in the manner that you

specify. If you give no instructions on the proxy card you execute, the shares covered by the proxy card will be

voted “FOR” the election of the nominees as directors and "FOR" the proposal to authorize the Company,

with the subsequent approval of its Board of Directors, to issue and sell shares of its common stock (during

the 12 months following such authorization) at a price below its then-current net asset value per share in one

or more offerings, subject to certain limitations set forth herein (including, without limitation, that the

number of shares issued and sold pursuant to such authority does not exceed 30% of the Company’s then-

outstanding common stock immediately prior to each such offering). If any other business is brought before

the Annual Meeting, your votes will be cast at the discretion of the proxy holders, subject to applicable

Securities and Exchange Commission (“SEC”) rules.

Any stockholder “of record” (i.e., stockholders holding shares directly in their name) giving a valid proxy for the

Annual Meeting may revoke it before it is exercised by giving a later-dated properly executed proxy, by giving

notice of revocation to the Company's Secretary in writing before the Annual Meeting or by voting electronically via

the live webcast of the Annual Meeting. However, the mere presence of the stockholder at the Annual Meeting does

not revoke the proxy. Any stockholder of record attending the Annual Meeting virtually by live webcast may vote

electronically whether or not he or she has previously authorized his or her shares to be voted by proxy.

If your shares are registered in the name of a bank, brokerage firm or other nominee, you will receive instructions

from your bank, broker, or other nominee that you must follow in order to instruct how your shares are to be voted at

the Annual Meeting. If your shares are registered in the name of a bank, brokerage firm or other nominee, to revoke

any voting instructions prior to the time the vote is taken at the Annual Meeting, you must contact such broker, bank

or other institution or nominee to determine how to revoke your vote in accordance with its policies a sufficient time

in advance of the Annual Meeting. Unless revoked as stated above, the shares of common stock represented by valid

proxies will be voted on all matters to be acted upon at the Annual Meeting.

If you want to submit a question during the Annual Meeting, log into the live webcast at

www.virtualshareholdermeeting.com/BBDC2025, type your question into the “Ask a Question” field, and click

“Submit.”

Only questions submitted via the live webcast that are pertinent to Annual Meeting matters will be answered during

the Annual Meeting, subject to time constraints. Questions or comments that are not related to the proposals under

discussion, are about personal concerns not shared by stockholders generally, or use blatantly offensive language

may be ruled out of order. Additionally, the Company may not be able to answer multiple questions submitted by

the same stockholder. The Company intends to post and answer questions pertinent to the Annual Meeting matters

that cannot be answered during the Annual Meeting due to time constraints online at the Company’s website at

https://ir.barings.com/annual-shareholder-meeting-materials. The questions and answers will be available as soon as

practicable after the Annual Meeting and will remain available until one week after posting.

PURPOSE OF ANNUAL MEETING

At the Annual Meeting, you will be asked to consider and vote on the following proposals:

1.To elect three Class I directors to serve for a three-year term and until their successors have been duly

elected and qualify (Proposal No. 1);

2.To approve a proposal to authorize the Company, pursuant to subsequent approval of its Board of

Directors, to issue and sell shares of its common stock (during the 12 months following such authorization)

at a price below the Company’s then-current net asset value per share in one or more offerings, subject to

certain limitations set forth herein (including, without limitation, that the number of shares issued and sold

pursuant to such authority does not exceed 30% of the Company’s then-outstanding common stock

immediately prior to each such offering) (Proposal No. 2); and

3.To transact such other business as may properly come before the meeting, or any postponement or

adjournment thereof.

The Board of Directors is not aware of any matter to be presented for action at the Annual Meeting other than the

matters set forth herein. Should any other matter requiring a vote of stockholders arise, it is the intention of the

persons named in the proxy to vote in accordance with their discretion on such matters. Stockholders have no

dissenters' or appraisal rights in connection with any of the proposals described herein.

Adjournment and Additional Solicitation

If there appear to be insufficient votes to obtain a quorum at the Annual Meeting, the chairman of the meeting may

adjourn the Annual Meeting to a later date or the stockholders who are represented in person (electronically via the

live webcast) or by proxy may vote to adjourn the Annual Meeting to permit further solicitation of proxies. If

adjournment is submitted to the stockholders for approval, the designated Company proxy holders will vote proxies

held by each of them for such adjournment to permit the further solicitation of proxies. Approval of any proposal to

adjourn the Annual Meeting submitted to the stockholders for approval requires the affirmative vote of a majority of

the votes cast on the proposal.

A stockholder vote may be taken on any of the proposals in this Proxy Statement prior to any such adjournment if

there are sufficient votes for approval of such proposal.

VOTING SECURITIES

You may vote at the Annual Meeting only if you were a holder of record of the Company's common stock at the

close of business on March 7, 2025 or if you hold a valid proxy from a stockholder of record as of such record date.

As of March 7, 2025, there were 105,408,938 shares of the Company's common stock outstanding. Each share of

common stock is entitled to one vote on each matter submitted to a vote at the Annual Meeting. Stockholders do not

have the right to cumulate votes in the election of directors.

QUORUM REQUIRED

A quorum must be present at the Annual Meeting for any business to be conducted. The presence at the Annual

Meeting, electronically via the live webcast or by proxy, of the holders of shares of common stock of the Company

entitled to cast a majority of the votes entitled to be cast as of the record date of March 7, 2025 will constitute a

quorum for the purposes of the Annual Meeting. If there are not sufficient votes for a quorum or to approve or ratify

any of the foregoing proposals at the time of the Annual Meeting, the chairman of the meeting may adjourn the

Annual Meeting in order to permit further solicitation of proxies by the Company.

Abstentions and broker non-votes, if any, will be treated as shares present for the purpose of determining a quorum

for the Annual Meeting. A “broker non-vote” with respect to a matter occurs when a broker, bank or other institution

or nominee holding shares on behalf of a beneficial owner returns a proxy but has not provided voting instructions

because it has not received voting instructions from the beneficial owner on a particular proposal and does not have,

or chooses not to exercise, discretionary authority to vote the shares on such proposals. If a stockholder does not

vote electronically via the live webcast or does not submit voting instructions to its broker, bank or other nominee,

the broker, bank or other nominee will only be permitted to vote the stockholder’s shares on “routine” proposals.

There are no “routine” proposals at the Annual Meeting. Therefore, the Company does not expect to receive any

broker non-votes at the Annual Meeting.

VOTES REQUIRED

Proposal No. 1

You may vote “For” or “Against” or abstain from voting on Proposal No. 1 (to elect three Class I directors to serve

for a term of three years, and until their successors are duly elected and qualify). For nominees for director listed in

Proposal No. 1 to be elected, each director nominee requires a majority of the votes cast for his or her election,

which means that each director nominee must receive more votes cast “FOR” than “AGAINST” that director

nominee. For purposes of the vote on this proposal, abstentions and broker non-votes, if any, will not be counted as

votes cast and will have no effect on the result of the vote, although they will be considered present for the purpose

of determining the presence of a quorum. If an incumbent director nominee does not receive the required number of

votes for re-election, then under Maryland law, he or she will continue to serve as a director of the Company until

his or her successor is duly elected and qualifies, subject to the Company's corporate governance guidelines

discussed further below.

Proposal No. 2

You may vote “For” or “Against” or abstain from voting on Proposal No. 2 (to authorize the Company, with the

subsequent approval of its Board of Directors, to issue and sell shares of its common stock (during the 12 months

following such authorization) at a price below its then-current net asset value per share in one or more offerings,

subject to certain limitations set forth herein (including, without limitation, that the number of shares issued and sold

pursuant to such authority does not exceed 30% of the Company’s then-outstanding common stock immediately

prior to each such offering)). To be approved, Proposal No. 2 must receive “FOR” votes from each of the following:

(1) a majority of the outstanding shares of the Company’s common stock; and (2) a majority of the outstanding

shares of the Company’s common stock that are not held by affiliated persons of the Company. For purposes of

Proposal No. 2, the Investment Company Act of 1940, as amended (the “1940 Act”), defines a “majority of the

outstanding shares” as the vote of the lesser of: (1) 67% or more of the voting securities of the Company present at

the Annual Meeting, if the holders of more than 50% of the outstanding voting securities of the Company are present

virtually or represented by proxy; or (2) more than 50% of the outstanding voting securities of the Company. For

purposes of the vote on Proposal No. 2, abstentions and broker non-votes, if any, will have the effect of votes cast

against the proposal.

HOW TO PARTICIPATE IN THE ANNUAL MEETING

The Annual Meeting will be conducted virtually, on Thursday, May 8, 2025 at 8:30 a.m. (Eastern Time) via live

webcast.

Stockholders of record can participate in the Annual Meeting virtually by logging in to

www.virtualshareholdermeeting.com/BBDC2025 and following the instructions provided. We recommend that you

registered stockholders as of March 7, 2025, the record date for the Annual Meeting, may submit questions and vote

at the Annual Meeting. You may still virtually participate in the Annual Meeting if you vote by proxy in advance of

the Annual Meeting.

Upon written request from a stockholder of record as of the record date, the Company's legal counsel, Dechert LLP,

will stream the webcast live at its offices located at 1900 K Street NW, Washington, DC 20006. Please note that no

members of the Company's management or the Board will be in attendance at this location. If you wish to attend the

Annual Meeting via webcast at the Washington, DC offices of Dechert LLP, please submit a written request to

Barings BDC, Inc., Attention: Corporate Secretary, 300 South Tryon Street, Suite 2500, Charlotte, NC 28202, to be

received no later than May 1, 2025. Your written request must include your name as stockholder of record and the

number of shares of the Company’s common stock you hold.

Please note that if you hold your shares through a bank, broker or other nominee (i.e., in street name), you may be

able to authorize your proxy by telephone or the Internet, as well as by mail. You should follow the instructions you

receive from your bank, broker or other nominee to vote these shares. Also, if you hold your shares in street name,

you must obtain a proxy executed in your favor from your bank, broker or nominee to be able to participate in and

vote via the Annual Meeting webcast.

The location, means, or other details of attending the webcast of the Annual Meeting at Dechert LLP's

Washington, DC offices may change. In the event of such a change, and if a stockholder of record has

requested to attend the meeting via webcast at Dechert LLP's Washington, DC offices, the Company will

issue a press release announcing the change and file the announcement on the SEC's EDGAR system, along

with other steps, but may not deliver additional soliciting materials to stockholders or otherwise amend the

proxy materials. The Company plans to announce these changes, if any, at https://ir.barings.com/, and

encourages you to check the “Investor Relations” and “Latest News” sections of this website prior to the

Annual Meeting if you plan to attend the webcast at the Washington, DC offices of Dechert LLP.

INFORMATION REGARDING THIS SOLICITATION

The Company will bear the cost of solicitation of proxies in the form accompanying this statement. Proxies will be

solicited by mail or by requesting brokers and other custodians, nominees and fiduciaries to forward proxy soliciting

material to the beneficial owners of shares of common stock held of record by such brokers, custodians, nominees

and fiduciaries, each of whom the Company will reimburse for its expenses in so doing. In addition to the use of

mail, directors, officers and regular employees of Barings LLC, the Company’s external investment adviser

(“Barings” or the “Adviser”), without special compensation therefor, may solicit proxies personally or by telephone,

electronic mail, facsimile or other electronic means from stockholders. The address of Barings LLC is 300 South

Tryon Street, Suite 2500, Charlotte, NC 28202.

The Company has engaged the services of Broadridge Financial Solutions, Inc. ("Broadridge") for the purpose of

assisting in the solicitation of proxies at an anticipated cost of approximately $54,000 plus reimbursement of certain

expenses and fees for additional services requested. We may also reimburse brokerage firms, banks and other agents

for the cost of forwarding proxy materials to beneficial owners and obtaining your voting instructions. Please note

that Broadridge may solicit stockholder proxies by telephone on behalf of the Company. They will not attempt to

influence how you vote your shares, but only ask that you take the time to authorize your proxy. You may also be

asked if you would like to authorize your proxy over the telephone and to have your voting instructions transmitted

to the Company’s proxy tabulation firm.

Stockholders may authorize proxies and provide their voting instructions through the Internet, by telephone, or by

mail by following the instructions on the proxy card. These options require stockholders to input the Control

Number, which is provided on the proxy card. If you authorize a proxy using the Internet, after visiting

www.proxyvote.com and inputting your Control Number, you will be prompted to provide your voting instructions.

Stockholders will have an opportunity to review their voting instructions and make any necessary changes before

submitting their voting instructions and terminating their Internet link. Stockholders who authorize a proxy via the

Internet, in addition to confirming their voting instructions prior to submission, will, upon request, receive an e-mail

confirming their instructions.

If a stockholder wishes to participate in the Annual Meeting but does not wish to authorize his, her or its proxy by

telephone or Internet, the stockholder may authorize a proxy by mail by completing and executing the

accompanying proxy card and returning it in the postage-paid envelope, or they may attend the Annual Meeting via

live webcast.

YOUR VOTE IS IMPORTANT. WHETHER OR NOT YOU PLAN TO ATTEND THE ANNUAL

MEETING VIRTUALLY, PLEASE PROMPTLY VOTE YOUR SHARES EITHER BY MAIL, BY

TELEPHONE, OR VIA THE INTERNET.

PROPOSAL NO. 1

ELECTION OF DIRECTORS

The Board of Directors is currently comprised of nine Directors divided into three (3) classes, with terms expiring in

2025, 2026 and 2027. The term of office of Class I Directors ends on the date of the Annual Meeting (or on the date

their respective successors are elected and qualify, if later).

The three Class I Directors of the Company—Eric Lloyd, Mark F. Mulhern, and Robert Knapp—have each been

nominated by the Board of Directors (upon the recommendation of the Nominating and Corporate Governance

Committee) for election for a three-year term expiring in 2028. No person being nominated as a Class I Director is

being proposed for election pursuant to any agreement or understanding between such person, on the one hand, and

the Company or any other person or entity, on the other hand. Each nominee for Class I Director has agreed to serve

as a director if elected and has consented to be named as a nominee.

Pursuant to the Company's Seventh Amended and Restated Bylaws (the “Bylaws”), a nominee for director is elected

to the Board of Directors if the number of votes cast for such nominee’s election exceed the number of votes cast

against such nominee’s election. Pursuant to the Company's corporate governance guidelines, incumbent directors

must agree to tender their resignation if they fail to receive the required number of votes for re-election, and in such

event the Board of Directors will act within 90 days following certification of the stockholder vote to determine

whether to accept the director’s resignation. These procedures are described in more detail in the Company's

corporate governance guidelines, which are available under “Governance Documents” on the Investor Relations

section of the Company's website at https://ir.barings.com/governancedocs. The Board of Directors may consider

any factors it deems relevant in deciding whether to accept a director’s resignation. If a director’s resignation offer is

not accepted by the Board of Directors, the Company expects that such director would continue to serve until his or

her successor is duly elected and qualifies, or until the director’s earlier death, resignation, or removal. Any such

director will be eligible for nomination for election as a director at future Annual Meetings.

The Board of Directors recommends that you vote “FOR” the election of each of the nominees named in this

proxy statement.

In the absence of instructions to the contrary, it is the intention of the persons named as proxies to vote such

proxy for the election of the nominees named below. If any such nominee should decline or be unable to serve

as a director, it is intended that the proxy will be voted for the election of such person who is nominated as a

replacement. The Board of Directors has no reason to believe that the nominees named below will be unable

or unwilling to serve.

Information about the Nominees for Director and Other Directors

The following chart summarizes the professional experience and additional considerations that contributed to the

Nominating and Corporate Governance Committee’s and the Board of Directors’ conclusion that each nominee for

Director and other Director should serve on the Board of Directors. The term “Fund Complex” included in the

director biographies included in this proxy statement includes the Company, Barings Capital Investment Corporation

(“BCIC”) (a non-listed business development company), Barings Private Credit Corporation (“BPCC”) (a

perpetually offered non-listed business development company), Barings Global Short Duration High Yield Fund (a

closed-end fund (NYSE: BGH)), Barings Corporate Investors (a closed-end fund (NYSE: MCI)), and Barings

Participation Investors (a closed-end fund (NYSE: MPV)). The director information in the following chart is

organized by class and, within each class, by “Interested Directors” and “Non-Interested Directors.” “Interested

Directors” are “interested persons,” as defined in Section 2(a)(19) of the 1940 Act, of the Company.

NOMINEES FOR CLASS I DIRECTORS


Name, Address and Age(1)	Position(s) Held with Company	Term and Length of Time Served	Principal Occupations During Past 5 Years	Number of Portfolios Overseen in Fund Complex (2)	Other Directorships of Public or Registered Investment Companies Held by Director or Nominee for Director During Past 5 Years
Interested Director
Eric Lloyd(3) (56)	Chief Executive Officer and Executive Chairman of the Board of Directors	Class I Director; Term Expires 2025; Director since August 2018	President (since 2021), Global Head of Private Assets (2020-2021), Deputy Head of Global Markets & Head of Private Fixed Income (2019-2020).	3	Director (since 2020), Chairman (since 2021), BCIC; Director (Chairman) (since 2021), BPCC.
Non-Interested Directors
Mark F. Mulhern (65)	Director	Class I Director; Term Expires 2025; Director since October 2016 (Triangle Capital)	Executive Vice President and Chief Financial Officer (2014 - 2022), Highwood Properties, Inc. (publicly traded real estate investment trust).	4	Director (since 2021), BPCC; Trustee (since 2021), Barings Global Short Duration High Yield Fund (closed-end investment company advised by Barings); Director (since 2020), Intercontinental Exchange (financial services company (NYSE: ICE)); Director (since 2020), ICE Mortgage Technology; Director (since 2020), BCIC; Trustee (2022-2024), Barings Private Equity Opportunities and Commitments Fund (a non-diversified, closed-end management investment company advised by Barings until February 2024).
Robert Knapp (59)	Director	Class I Director; Term Expires 2025; Director since December 2020	Chief Investment Officer (since 2007), Ironsides Partners LLC (investment management firm).	1	Director (since 2007), Africa Opportunity Fund Ltd.; Director (since 2010), Pacific Alliance Asia Opportunity Fund and Pacific Alliance Group Asset Management Ltd.; Director (since 2010), Sea Education Association; Director (since 2015), Lamington Road DAC (successor to Emergent Capital Inc.); Director (since 2024), DP Aircraft, Ltd.; Director (since 2018), Okeanis Eco Tankers Corp.; Director (2017-2023), Children's School of Science; Director (2016-2022), Mass Eye & Ear; Director (2003-2020), MVC Capital.

(1)The business address of each nominee for director is 300 South Tryon Street, Suite 2500, Charlotte, NC 28202. The age

of each individual is as of the date of the Annual Meeting.

(2) Including the Company.

(3)Interested Director due to affiliations with Barings LLC.

CLASS II DIRECTORS: TERM EXPIRING 2026


Name, Address and Age(1)	Position(s) Held with Company	Term and Length of Time Served	Principal Occupations During Past 5 Years	Number of Portfolios Overseen in Fund Complex (2)	Other Directorships of Public or Registered Investment Companies Held by Director or Nominee for Director During Past 5 Years
Non-Interested Directors
Steve Byers (71)	Director	Class II Director; Term expires 2026; Director since February 2022	Independent Consultant (since 2014).	1	Director (since 2011), Chairman (since 2016) Deutsche Bank DBX ETF Trust; Trustee (since 2016), The Arbitrage Funds Trust; Director (2012-2022), Chairman (2012-2022), Sierra Income Corporation.
Valerie Lancaster- Beal (70)	Director	Class II Director; Term expires 2026; Director since February 2022	President and Chief Executive Officer (since 2014), VRL Associates, LLC (management consulting firm providing financial and operational advisory services); Chief Financial Officer (2015-2021), Odyssey Media (marketing and communications company).	1	Director (2012-2022), Sierra Income Corporation; Director (2012 - 2022), KIPP NYC.
John A. Switzer (68)	Director	Class II Director; Term expires 2026; Director since August 2018	Director, Weisiger Group (formerly Carolina Tractor and Equipment Company (CTE)) (since 2017).	2	Director (since 2021), BCIC; Director and Audit Committee member (since 2019), HomeTrust Bancshares, Inc. (financial services company).

(1)The business address of each director is 300 South Tryon Street, Suite 2500, Charlotte, NC 28202. The age of each

individual is as of the date of the Annual Meeting.

(2)Including the Company.

CLASS III DIRECTORS: TERM EXPIRING 2027


Name, Address and Age(1)	Position(s) Held with Company	Term and Length of Time Served	Principal Occupations During Past 5 Years	Number of Portfolios Overseen in Fund Complex (2)	Other Directorships of Public or Registered Investment Companies Held by Director or Nominee for Director During Past 5 Years
Interested Director
David Mihalick(3) (52)	Director	Class III Director; Term expires 2027; Director since November 2020	Co-Head of Global Investments (since 2025), Head of Private Assets (2021 - 2025), Head of U.S. Public Fixed Income and Member of Global Investment Grade Allocation Committee (2019-2021), Head of U.S. High Yield and Member of Global High Yield Allocation Committee (2017-2021), Barings LLC (global asset manager).	5	Director (since 2021), BCIC; Trustee (since 2020), Barings Global Short Duration High Yield Fund (closed-end investment company advised by Barings); Trustee (since 2022), Barings Corporate Investors (a closed-end fund advised by Barings); Trustee (since 2022), Barings Participation Investors (a closed-end fund advised by Barings); Trustee (2020-2021), Barings Funds Trust (open-end investment company advised by Barings until 2021).


Non-Interested Directors
Thomas W. Okel (62)	Director	Class III Director; Term expires 2027; Director since August 2018	Executive Director (2011 - 2019), Catawba Lands Conservancy (nonprofit, community-based conservation organization).	4	Director (since 2021), BPCC; Director (since 2020), BCIC; Trustee (since 2012), Barings Global Short Duration High Yield Fund (closed-end investment company advised by Barings); Trustee / Board Chair (since 2015), Horizon Funds (mutual fund complex); Trustee (2013-2021), Barings Funds Trust (open-end investment company advised by Barings until 2021); Trustee (2022-2024), Barings Private Equity Opportunities and Commitments Fund (a non- diversified, closed-end management investment company advised by Barings until February 2024).
Jill Olmstead (61)	Director	Class III Director; Term expires 2027; Director since August 2018	Chief Human Resources Officer, (since 2018), LendingTree, Inc. (online lending and realty services exchange).	4	Director (since 2021), BPCC; Trustee (since 2021), Barings Global Short Duration High Yield Fund (closed-end investment company advised by Barings); Director (since 2020), BCIC; Trustee (2022-2024), Barings Private Equity Opportunities and Commitments Fund (a non- diversified, closed-end management investment company advised by Barings until February 2024).

(1)The business address of each director is 300 South Tryon Street, Suite 2500, Charlotte, NC 28202. The age of each

individual is as of the date of the Annual Meeting.

(2)Including the Company.

(3)Interested Director due to affiliations with Barings LLC.

Qualifications of Director Nominees and Other Directors.

The following provides an overview of the considerations that led the Nominating and Corporate Governance

Committee and the Board of Directors to recommend and approve the election or appointment of the individuals

serving as a Director or nominee for Director. Each of the Directors has demonstrated superior credentials and

recognition in his or her respective field and the relevant expertise and experience upon which to be able to offer

advice and guidance to the Company’s management. In recommending the election or appointment of the Board

members or nominees, the Nominating and Corporate Governance Committee generally considers certain factors

including the current composition of the Board of Directors, overall business expertise, gender, cultural and racial

diversity, whether the composition of the Board of Directors contains a majority of independent directors as

determined under the NYSE listing standards and the 1940 Act, the candidate’s character and integrity, whether the

candidate possesses an inquiring mind, vision and the ability to work well with others, conflicts of interest

interfering with the proper performance of the responsibilities of a director, a candidate’s overall business

experience, what type of diversity he or she brings to the Board of Directors, whether the candidate has sufficient

time to devote to the affairs of the Company, including consistent attendance at Board of Directors and committee

meetings and advance review of materials and whether each candidate can be trusted to act in the best interests of

the Company and its stockholders.

Nominees for Class I Directors; Term expiring at the 2025 Annual Stockholder Meeting

•Mr. Lloyd — Mr. Lloyd brings over 30 years of experience in investment management, investment

banking, leveraged finance and risk management to the Board of Directors. Mr. Lloyd is President of

Barings LLC where he leads and manages cross-asset investment teams and corporate strategy, business

development, product management, investment business management, research analytics and quant,

permanent capital, special situations, marketing and communication. Mr. Lloyd also works closely with all

the investment teams at Barings LLC. Prior to his current role, Mr. Lloyd served as Head of Private Assets.

Mr. Lloyd has worked in the industry since 1990 and his experience has encompassed leadership positions

in investment management, investment banking, leveraged finance and risk management. Prior to joining

Barings in 2013, Mr. Lloyd served as Head of Market and Institutional Risk for Wells Fargo, was on Wells

Fargo’s Management Committee and was a member of the Board of Directors of Wells Fargo Securities.

Before the acquisition of Wachovia, Mr. Lloyd worked in Wachovia’s Global Markets Investment Banking

division and served on the division’s Operating Committee where he had various leadership positions,

including Head of Wachovia’s Global Leveraged Finance Group. Mr. Lloyd also serves as the Chairman of

the Board of Directors for each of BPCC and BCIC, each of which is an affiliate of the Company. Mr.

Lloyd holds a B.S. in Finance from the University of Virginia's McIntire School of Commerce.

•Mr. Mulhern — Mr. Mulhern brings significant public company experience, both as a senior executive and

as a board member. From September 2014 until his retirement on January 1, 2022, he served as Executive

Vice President and Chief Financial Officer of Highwoods Properties, Inc., a Raleigh, North Carolina based

publicly-traded real estate investment trust. Prior to joining Highwoods, Mr. Mulhern served as Executive

Vice President and Chief Financial Officer of Exco Resources, Inc. Prior to Exco, he served as Senior Vice

President and Chief Financial Officer of Progress Energy, Inc. from 2008 until its merger with Duke

Energy Corporation in 2012. He joined Progress Energy in 1996 as Vice President and Controller and

served in a number of leadership roles at Progress Energy, including Vice President of Strategic Planning,

Senior Vice President of Finance and President of Progress Ventures. He also spent eight years at Price

Waterhouse, now known as PwC. Mr. Mulhern previously served on the Highwoods Board of Directors

and Audit Committee from January 2012 through August 2014. He currently serves on the boards of BPCC

and BCIC, as well as Barings Global Short Duration High Yield Fund. Additionally, Mr. Mulhern serves on

the board of the Intercontinental Exchange, a Fortune 500 company and provider of marketplace

infrastructure, data service and technology solutions to a broad range of customers. He also serves on the

board of ICE Mortgage Technology, a subsidiary of the Intercontinental Exchange. Mr. Mulhern is a

Certified Public Accountant and is a graduate of St. Bonaventure University.

•Mr. Knapp — Mr. Knapp brings over 25 years of experience in the financial services industry to the Board

of Directors. He is the Founder and Chief Investment Officer of Ironsides Partners LLC, a Boston-based

investment manager specializing in closed-end funds, holding companies, and asset value investing

generally. Ironsides and related entities serve as the manager and general partner to various funds and

managed accounts for institutional clients. Mr. Knapp is also a director of DP Aircraft Ltd., Okeanis Eco

Tankers, the Pacific Alliance Asia Opportunity Fund and its related entities and Pacific Alliance Group

Asset Management Ltd., based in Hong Kong, and Lamington Road DAC, the successor to Emergent

Capital. He is a principal and director of Africa Opportunity Partners Limited, a Cayman Islands company

that serves as the investment manager to Africa Opportunity Fund Limited. Additionally, Mr. Knapp serves

as a member of the Board of Managers of Veracity Worldwide LLC and is Chairman of Ironsides Medical,

Inc. Mr. Knapp previously served as the Lead Independent Director of MVC Capital, Inc. until completion

of its merger with the Company in December 2020. He also acted as Managing Director for over ten years

at Millennium Partners in New York. In the non-profit sector, Mr. Knapp serves as a Trustee and Treasurer

of the Sea Education Association, both based in Woods Hold, Massachusetts.

Directors Continuing in Office

Class II Directors; Term expiring at the 2026 Annual Stockholder Meeting

•Mr. Byers — Mr. Byers is a senior executive with over 30 years of leadership experience in finance,

operations and control, investment management and capital markets with leading national firms in asset

management, banking and brokerage. Mr. Byers serves as the Independent Chairman of the Board of

Directors of Deutsche Bank DBX ETF Trust and as a member of the audit and nominating committees.

Since 2016, Mr. Byers has also served as a board member of the Mutual Fund Directors Forum, an

independent, non-profit organization serving independent directors of U.S. funds registered with the SEC

under the 1940 Act, and as a Trustee of the Arbitrage Fund Trust, an open-end management investment

company registered with the SEC under the 1940 Act. Mr. Byers served as an Independent Director and

Chairman of Sierra Income Corporation, a non-traded business development company sponsored by

Medley LLC (NYSE:MCC), from 2012 to 2022. Sierra Income merged with the Company in February,

2022, in connection with which Mr. Byers was appointed to the Board of Directors of the Company. From

2002 to 2012, Mr. Byers also served as Trustee for the College of William and Mary Graduate School of

Business. Since 2014, Mr. Byers has been engaged periodically as an independent consultant to provide

expert reports and opinions in financial and investment related matters. From 2000 to 2006, Mr. Byers

served as an investment executive with Dreyfus Corporation and served as Vice Chairman, Executive Vice

President, Chief Investment Officer, member of the Board of Directors and Executive Committee, and fund

officer of 90 investment companies, responsible for investment performance of approximately $200 billion

in assets under management. Prior to joining Dreyfus Corporation, Mr. Byers served in executive positions

at PaineWebber Group from 1986 to 1997, and served in such capacities as chairman of the Investment

Policy and Risk Oversight Committee, Capital Markets Director of Risk and Credit Management, and was

NASD registered as General Principal, Financial and Operations Principal and Branch Principal. Prior to

PaineWebber, Mr. Byers was an executive at Citibank/Citicorp from 1979 to 1986. Mr. Byers received his

M.B.A. in Finance from Roth Graduate School of Business, Long Island University and his B.A. in

Economics from Long Island University. In December 2014, Mr. Byers was recognized by the National

Association of Corporate Directors as a Board Leadership Fellow.

•Ms. Lancaster-Beal — Ms. Lancaster-Beal is a financial professional with extensive management and

board level experience in corporate governance, credit and financial analysis. Ms. Lancaster-Beal is the

President and Chief Executive Officer of VRL Associates, a management consulting firm she founded in

January 2014 that provides financial and operational advisory services to middle-market businesses,

investment firms and non-profit organizations. In this capacity, she previously served as the Chief

Financial Officer of Odyssey Media from 2015 to 2021, and as the Chief Administrative and Finance

Director of Data Capital Management from 2015 to 2017. Prior to this, she served as Managing Director at

M.R. Beal & Company, which she co-founded in April 1988, until 2014. Ms. Lancaster-Beal was a Senior

Vice President of Drexel Burnham Lambert from 1984 to 1988 and as Vice President of Citicorp

Investment Bank from 1978 to 1984. Ms. Lancaster-Beal served as an Independent Director and Chair of

the Nominating and Governance committee and the Audit committee of Sierra Income Corporation, a non-

traded business development company (BDC) sponsored by Medley LLC (NYSE:MCC), from 2012 to

2022. Sierra Income merged with the Company in February 2022, in connection with which Ms. Lancaster-

Beal was appointed to the Board of Directors of the Company. Ms. Lancaster-Beal previously served on the

Board of Directors of KIPP NYC, a network of free, public charter schools from 2012 to 2022. Ms.

Lancaster-Beal holds a B.A. in Economics from Georgetown University and an M.B.A. from the Wharton

School of Business of the University of Pennsylvania.

•Mr. Switzer — Mr. Switzer brings over 35 years of public accounting firm experience to the Board of

Directors. Mr. Switzer has served as a member of the Board of Directors of BCIC since March 2021, and

has served as a member of the Board of Directors of Weisiger Group (formerly Carolina Tractor and

Equipment Company (CTE)), a large, privately held Southeastern supplier of construction, forestry, paving,

and material handling equipment since 2017. Since 2019, Mr. Switzer has also served as a member of the

Board of Directors of HomeTrust Bancshares, Inc., a publicly traded regional banking organization, where

he also serves on the Audit Committee. Previously, Mr. Switzer served as managing partner of KPMG's

Charlotte office (starting in 2009) until retirement in 2016, where he was also the market leader for

KPMG’s Carolinas, Florida, and San Juan offices. Prior to these positions, he served as managing partner

of KPMG’s Cleveland (1999 to 2007) and Kentucky (Louisville and Lexington) (1988 to 1998) offices. Mr.

Switzer also currently serves on the board of The Foundation for the Mint Museum. Mr. Switzer is a

Certified Public Accountant and holds a B.S. in Accounting from the University of Kentucky.

Class III Directors; Term expiring at the 2027 Annual Stockholder Meeting

•Mr. Mihalick — Mr. Mihalick brings over 16 years of experience in the financial services industry to the

Board of Directors. He is Barings LLC's Co-Head of Global Investments, responsible for the oversight of

Barings LLC's global investment platform spanning public and private markets in fixed income, real assets

and capital solutions. He is also a member of Barings LLC's Senior Leadership Team. Prior to his current

role, Mr. Mihalick served as Head of Private Assets, managing the firm's global private markets businesses,

including direct middle-market lending, private placements, infrastructure debt, private structured finance,

diversified alternative equity and real estate. Prior to that, Mr. Mihalick served as Head of U.S. Public

Fixed Income, and Head of U.S. High Yield, where he was responsible for the U.S. High Yield and

Investment Grade Investment Groups. Prior to joining Barings LLC in 2008, he was a Vice President with

Wachovia Securities Leveraged Finance Group. At Wachovia (now Wells Fargo) he was responsible for

sell-side origination of leveraged loans and high yield bonds to support both corporate and private equity

issuers. Prior to entering the financial services industry, he served as an officer in the United States Air

Force and worked in the telecommunications industry for 7 years. Mr. Mihalick serves as a trustee or

director of BCIC, Barings Global Short Duration High Yield Fund, Barings Corporate Investors and

Barings Participation Investors, both closed-end funds advised by Barings. Mr. Mihalick holds a B.S. from

the United States Air Force Academy, an M.S. from the University of Washington and an M.B.A. from

Wake Forest University.

•Mr. Okel — Mr. Okel brings over 20 years of experience in the underwriting, structuring, distribution and

trading of debt used for corporate acquisitions, leveraged buyouts, recapitalizations and refinancings to the

Board of Directors. He previously served from 2011 to 2019 as Executive Director of Catawba Lands

Conservancy, a non-profit land trust. Prior to joining Catawba Lands Conservancy, he served as Global

Head of Syndicated Capital Markets at Bank of America Merrill Lynch, where he managed capital markets,

sales, trading and research for the United States, Europe, Asia and Latin America from 1989 to 2010. He

currently serves as trustee or director of several public companies and non-profit organizations, including

BPCC, BCIC and Barings Global Short Duration High Yield Fund; and is Chairman of the Board of

Directors of Horizon Funds, a mutual fund complex. Mr. Okel holds a Bachelor of Arts in Economics from

Davidson College and a Masters of Management, Finance, Accounting and Marketing from Kellogg School

of Management, Northwestern University.

•Ms. Olmstead — Ms. Olmstead brings over 21 years of senior leadership experience in Human Resources

in the financial services industry to the Board of Directors. She has served as Chief Human Resources

Officer at LendingTree, Inc., since 2018 and was a Founding Partner of Spivey & Olmstead, LLC, a Talent

and Leadership Consulting firm with expertise in the fields of executive development and talent

management founded in June 2010. She also currently serves on the boards of BPCC, BCIC and Barings

Global Short Duration High Yield Fund. The Board benefits from her experience with C-suite executives in

helping lead companies' efforts on talent strategies, including succession planning, building strong

performance cultures, and diversity and inclusion work. She has a strategic and pragmatic approach to

talent management with an eye toward bottom line results. In her capacity as Managing Director (2006 to

2009) and Executive Vice President (2000 to 2006) at Wachovia Corporation (now Wells Fargo) she was

both the Head of Human Resources for the Corporate and Investment Bank and the Head of Human

Resources for the International Businesses. Prior to this, she formed and led the Leadership Practices Group

at Wachovia to create and implement a company-wide talent management process that identified,

developed, tracked and promoted high potential leaders throughout their careers. Ms. Olmstead received a

Bachelor of Science at Clemson University and a Masters in Organization Behavior and Development at

Fielding University, Santa Barbara, California.

COMPENSATION DISCUSSION

We do not currently have any employees and do not expect to have any employees. The Company’s executive

officers are employees of Barings and do not receive any direct compensation from the Company. Barings serves as

our external investment adviser and manages the Company’s investment portfolio under the terms of a third

amended and restated investment advisory agreement (the "Advisory Agreement"), in connection with which the

Company pays Barings a base management fee and an incentive fee, the details of which are disclosed in the

Company’s annual report on Form 10-K for the fiscal year ended December 31, 2024, which is being delivered to

stockholders along with this proxy statement.

The Company’s day-to-day investment operations are managed by Barings and services necessary for its business,

including the origination and administration of its investment portfolio are provided by individuals who are

employees of Barings, as investment adviser and administrator, pursuant to the terms of the Advisory Agreement

and an administration agreement (the "Administration Agreement"). The Company reimburses Barings, in its

capacity as administrator, for the costs and expenses incurred by it in performing its obligations and providing

personnel and facilities under the Administration Agreement in an amount to be negotiated and mutually agreed to

by the Company and Barings quarterly in arrears. In no event will the agreed-upon quarterly expense amount exceed

the amount of expenses that would otherwise be reimbursable by the Company under the Administration Agreement

for the applicable quarterly period, and Barings will not be entitled to the recoupment of any amounts in excess of

the agreed-upon quarterly expense amount. The costs and expenses incurred by Barings on our behalf under the

Administration Agreement include, but are not limited to:

▪the allocable portion of Barings' rent for the Company’s Chief Financial Officer and Chief Compliance

Officer and their respective staffs, which is based upon the allocable portion of the usage thereof by such

personnel in connection with their performance of administrative services under the Administration

Agreement;

▪the allocable portion of the salaries, bonuses, benefits and expenses of the Company’s Chief Financial

Officer and Chief Compliance Officer and their respective staffs, which is based upon the allocable portion

of the time spent by such personnel in connection with performing administrative services for the Company

under the Administration Agreement;

▪the actual cost of goods and services used for the Company and obtained by Barings from entities not

affiliated with the Company, which is reasonably allocated to the Company on the basis of assets, revenues,

time records or other methods conforming with generally accepted accounting principles;

▪all fees, costs and expenses associated with the engagement of a sub-administrator, if any; and

▪costs associated with (a) the monitoring and preparation of regulatory reporting, including filings with the

SEC and tax reporting, (b) the coordination and oversight of service provider activities and the direct cost

of such contractual matters related thereto and (c) the preparation of all financial statements and the

coordination and oversight of audits, regulatory inquiries, certifications and sub-certifications.

Timing of Grants of Options

The Company did not grant awards of stock options, stock appreciation rights or similar option-like instruments

during the fiscal year ended December 31, 2024. Accordingly, we have nothing to report under Item 402(x) of

Regulation S-K.

DIRECTOR COMPENSATION

The Company's directors are divided into two groups — Interested Directors and Independent Directors. Interested

Directors are “interested persons” as defined in Section 2(a)(19) of the 1940 Act. During 2024, Interested Directors

did not receive any compensation from the Company for their service as members of the Board of Directors. The

compensation table below sets forth compensation that the Company's Independent Directors earned during the year

ended December 31, 2024.


Name	Fees Earned or Paid in Cash	All Other Compensation(1)	Total
Mark Mulhern ...........................................................	$130,000	$—	$130,000
John A. Switzer .........................................................	$120,000	$—	$120,000
Thomas W. Okel .......................................................	$130,000	$—	$130,000
Jill Olmstead .............................................................	$120,000	$—	$120,000
Robert Knapp ............................................................	$120,000	$—	$120,000
Steve Byers ...............................................................	$120,000	$—	$120,000
Valerie Lancaster-Beal ..............................................	$120,000	$—	$120,000

(1)All other compensation includes reimbursement of out-of-pocket expenses

Director Fees

During the year ended December 31, 2024, each Independent Director of the Board of Directors was paid an annual

board retainer of $120,000, payable by the Company in quarterly installments, and the Board’s lead independent

director and the chair of the Board’s Audit Committee each received an additional $10,000 annual retainer in

recognition of the increased responsibilities associated with each such position. For the year ending December 31,

2025, each Independent Director of the Board of Directors will be paid an annual board retainer of $150,000,

payable by the Company in quarterly installments, and the Board's lead independent director and the chair of the

Board's Audit Committee will each receive an additional $20,000 annual retainer in recognition of the increased

responsibilities associated with each such position.

In addition, the Company reimburses Independent Directors for any out-of-pocket expenses related to their service

as members of the Board of Directors. The Independent Directors of the Board of Directors do not receive any

stock-based compensation for their service as members of the Board of Directors. The Company's Interested

Directors do not receive any compensation from the Company for their service as members of the Board of

Directors.

CORPORATE GOVERNANCE

Director Independence

The Board of Directors has a majority of directors who are independent under the listing standards of the New York

Stock Exchange (“NYSE”) and the 1940 Act. The NYSE Listed Company Rules provide that a director of a BDC

shall be considered to be independent if he or she is not an "interested person" of the Company, as defined in

Section 2(a)(19) of the 1940 Act. Section 2(a)(19) of the 1940 Act defines an "interested person" to include, among

other things, any person who has, or within the last two years had, a material business or professional relationship

with the Company.

The Board of Directors has determined that Mses. Olmstead and Lancaster-Beal and Messrs. Mulhern, Okel,

Switzer, Knapp, and Byers are independent (or not “interested persons” of the Company). Based upon information

requested from each such director concerning his or her background, employment and affiliations, the Board of

Directors has affirmatively determined that none of the independent directors has a material business or professional

relationship with the Company, other than in his or her capacity as a member of the Board of Directors or any

committee thereof. None of the members of the Audit Committee, the Compensation Committee and the

Nominating and Corporate Governance Committee are "interested persons," as defined in Section 2(a)(19) of the

1940 Act, of the Company.

Meetings of the Board of Directors and Committees

In 2024, the Board of Directors held five meetings of the Board of Directors, as well as four Audit Committee

meetings, one Compensation Committee meeting, and one Nominating and Corporate Governance Committee

meeting. During 2024, none of the members of the Board of Directors attended less than 75% of the aggregate

number of meetings of the Board of Directors and of the respective committees on which they served.

Each of the Company's directors makes a diligent effort to attend all board and committee meetings, as well as each

Annual Meeting of Stockholders. We encourage, but do not require, our directors to attend annual meetings of

stockholders. Eight members of the then-constituted Board of Directors attended the Company's 2024 Annual

Meeting of Stockholders.

Audit Committee

The Company has a separately designated standing Audit Committee, as defined in Section 3(a)(58)(A) of the

Securities Exchange Act of 1934, as amended (the “Exchange Act”). The Audit Committee is responsible for

oversight matters, financial statement and disclosure oversight matters, matters relating to the hiring, retention and

oversight of the Company’s independent registered public accounting firm, reviewing the plans, scope and results of

the audit engagement with the Company’s independent registered public accounting firm, approving professional

services provided by the Company’s independent registered public accounting firm, reviewing the independence of

the Company’s independent registered public accounting firm, reviewing the integrity of the audits of the financial

statements and reviewing the adequacy of the Company’s internal accounting controls. The Audit Committee also

assists our Board of Directors in establishing and monitoring the application of the valuation policies used for

determining the fair value of the Company’s investments that are not publicly traded or for which current market

values are not readily available.

The Audit Committee Charter is publicly available under “Governance Documents” on the Investor Relations

section of the Company’s website at https://ir.barings.com/governance-docs. The contents of the Company’s website

are not intended to be incorporated by reference into this proxy statement or in any other report or document it files

with the SEC, and any references to the Company’s website are intended to be inactive textual references only.

The members of the Company’s Audit Committee are Messrs. Mulhern, Okel, Switzer, Knapp and Byers and Mses.

Olmstead and Lancaster-Beal. Messrs. Mulhern and Okel and Ms. Olmstead simultaneously serve on the audit

committees of more than three public companies, and the Board has determined that each of their simultaneous

service on the audit committees of other public companies does not impair their ability to effectively serve on the

Audit Committee. Mr. Mulhern serves as the chairman of the Audit Committee. The Board of Directors has

determined that Mr. Mulhern is an “audit committee financial expert” as defined under Item 407(d)(5) of Regulation

S-K of the Exchange Act and that all members of the Audit Committee are financially literate under NYSE listing

standards. The Board of Directors also has determined that each of Messrs. Mulhern, Okel, Switzer, Knapp, and

Byers and Mses. Olmstead and Lancaster-Beal meets the current independence requirements of Rule 10A-3 of the

Exchange Act and NYSE listing standards.

Compensation Committee

The Compensation Committee is responsible for determining, or recommending to the Board of Directors for

approval, the compensation of the Company’s independent directors; determining, or recommending to the Board of

Directors for determination, the compensation, if any, of the Company’s chief executive officer and all other

executive officers of the Company; and assisting the Board of Directors with matters related to compensation

generally.

In connection with reviewing, and recommending to the Board of Directors, the compensation of the independent

directors, the Compensation Committee evaluates the independent directors’ performance in light of goals and

objectives relevant to the independent directors and sets independent directors’ compensation based on such

evaluation and such other factors as the Compensation Committee deems appropriate and in the best interests of the

Company (including the cost to the Company of such compensation and a review of data of comparable business

development companies).

Currently none of the Company’s executive officers is compensated by the Company and, as a result, the

Compensation Committee does not produce and/or review a report on executive compensation practices. The

Compensation Committee also has the authority to engage compensation consultants, legal counsel or other advisors

(each, a “Consultant”) following consideration of certain factors related to such Consultants’ independence and has

the authority to form and delegate any of its responsibilities to a subcommittee of the Compensation Committee. The

Compensation Committee Charter is available under “Governance Documents” on the Investor Relations section of

our website at https://ir.barings.com/governance-docs.

The members of the Compensation Committee are Messrs. Mulhern, Okel, Switzer, Knapp and Byers, and Mses.

Olmstead and Lancaster-Beal, each of whom is not an "interested person" for purposes of Section 2(a)(19) of the

1940 Act and is independent under the applicable NYSE corporate governance listing standards. Ms. Olmstead

serves as the chair of the Compensation Committee. No members of the Compensation Committee during 2024 had

any relationship with the Company requiring disclosure under Item 404 of Regulation S-K under the Exchange Act.

Compensation Committee Interlocks and Insider Participation

No interlocking relationship, as defined by the rules adopted by the SEC, existed during the year ended

December 31, 2024 between any member of the Board of Directors or the Compensation Committee and an

executive officer of the Company.

Nominating and Corporate Governance Committee

The Nominating and Corporate Governance Committee is responsible for identifying, researching and

recommending for nomination directors for election by the Company's stockholders, recommending for appointment

nominees to fill vacancies on the Board of Directors or a committee of the Board of Directors, developing and

recommending to the Board of Directors a set of corporate governance principles and overseeing the evaluation of

the Board of Directors. The Nominating and Corporate Governance Committee’s policy is to consider nominees

properly recommended by the Company's stockholders in accordance with the Company's charter, Bylaws and

applicable law. For more information on how the Company's stockholders may recommend a nominee for a seat on

the Board of Directors, see "Stockholder Nominations and Proposals for the 2026 Annual Meeting" in this proxy

statement. The Nominating and Corporate Governance Committee also has the authority to retain, at the Company’s

expense, such consultants or advisors as the Committee may deem necessary or appropriate to carry out its duties.

The Committee has sole authority to retain or terminate any search firm or individual used to identify any director

candidate, including the sole authority to approve the search firm’s fees and retention terms.

The Nominating and Corporate Governance Committee Charter is publicly available under “Governance

Documents” on the Investor Relations section of the Company's website at https://ir.barings.com/governance-docs.

The members of the Nominating and Corporate Governance Committee are Messrs. Mulhern, Okel, Switzer, Knapp,

and Byers and Mses. Olmstead and Lancaster-Beal, each of whom is not an "interested person" for purposes of

Section 2(a)(19) of the 1940 Act and is independent under the NYSE corporate governance listing standards.

Mr. Okel serves as the chairman of the Nominating and Corporate Governance Committee. Each nominee for

election under Proposal No. 1 at the Annual Meeting was recommended by the members of the Nominating and

Corporate Governance Committee to the Board of Directors, which approved such nominees.

Communication with the Board of Directors

Barings BDC, Inc. stockholders and other interested parties may communicate with any member of our Board

(including the chairman), the chairman of any of our Board committees, or with our non-management directors as a

group by sending communications to Barings BDC, Inc., 300 South Tryon St., Suite 2500, Charlotte, North Carolina

28202, or via e-mail to BDCinvestorrelations@barings.com, or by calling the Barings BDC, Inc.’s investor relations

department at 1-888-401-1088. All such communications should indicate clearly the director or directors to whom

the communication is being sent so that each communication, other than unsolicited commercial solicitations, may

be forwarded directly to the appropriate director(s).

The Composition of the Board of Directors and Leadership Structure

The 1940 Act requires that at least a majority of the Company’s directors not be “interested persons” (as defined in

the 1940 Act) of the Company. Currently, seven of the Company’s nine directors have been determined to qualify as

independent directors (and to not be “interested persons”). Mr. Lloyd, our Chief Executive Officer and the President

of Barings LLC, and therefore an interested person of the Company, serves as Executive Chairman of the Board of

Directors. The Board of Directors believes that it is in the best interests of investors for Mr. Lloyd to lead the Board

of Directors because of his role as Chief Executive Officer of the Company and President of Barings LLC and his

broad experience with the day-to-day management of cross-asset class investment teams, corporate strategy,

business development and product management. In addition, the Board of Directors has designated Mr. Okel as lead

independent director to preside over all executive sessions of independent directors. The Board of Directors believes

that its leadership structure is appropriate in light of the Company’s characteristics and circumstances because the

structure allocates areas of responsibility among the individual directors and the committees in a manner that

enhances effective oversight. The Board of Directors also believes that its meeting frequency and governance

structure provides ample opportunity for direct communication and interaction between the Board of Directors and

the Company’s management.

The Oversight Role of the Board of Directors

The Board of Directors’ role in management of the Company is one of oversight. Oversight of the Company’s

investment activities extends to oversight of the risk management processes employed by Barings as part of its day-

to-day management of the Company’s investment activities. The Board of Directors reviews risk management

processes throughout the year, consulting with appropriate representatives of Barings as necessary and periodically

requesting the production of risk management reports or presentations and receiving reports from vendors and

service providers regarding cybersecurity threats and incidents. The goal of the Board of Directors’ risk oversight

function is to ensure that the risks associated with the Company’s investment activities are accurately identified,

thoroughly investigated and responsibly addressed. The Audit Committee (which consists of all the independent

directors) is responsible for approving the Company’s independent accountants, reviewing with the Company’s

independent accountants the plans and results of the audit engagement, approving professional services provided by

the Company’s independent accountants, reviewing the independence of the Company’s independent accountants

and reviewing the adequacy of the Company’s internal accounting controls. The Audit Committee also monitors the

application of the valuation policies used for determining the fair value of the Company’s investments that are not

publicly traded or for which current market values are not readily available. Stockholders should note, however, that

the Board of Directors’ oversight function cannot eliminate all risks or ensure that particular events do not adversely

affect the value of investments.

In accordance with the 1940 Act, the Company’s directors have adopted and implemented written policies and

procedures reasonably designed to prevent violation of the U.S. federal securities laws, and the Company reviews

these compliance policies and procedures annually for their adequacy and the effectiveness of their implementation.

In addition, the Board has designated Itzbell Branca as the Company’s Chief Compliance Officer. As such, Ms.

Branca is responsible for administering the Company’s compliance program and meeting with the Board of

Directors at least annually to assess its effectiveness.

Code of Business Conduct and Ethics and Corporate Governance Guidelines

The Company and Barings are subject to Barings LLC's Global Code of Ethics Policy, and the Company has

adopted a set of corporate governance guidelines covering ethics and business conduct. These documents apply to

the Company's directors and officers, among other Barings employees. Barings LLC's Global Code of Ethics Policy

and the Company's corporate governance guidelines are available on the Investor Relations section of the Company's

website at https://ir.barings.com/governance-docs. Any material amendments to or waivers of a required provision

of the Barings LLC Global Code of Ethics Policy and/or the Company's corporate governance guidelines will be

reported on our website and/or in a Current Report on Form 8-K within four business days of the amendment or

waiver.

Insider Trading Policy and Prohibitions and Restrictions on Hedging and Pledging Transactions

Under Barings LLC’s Global Code of Ethics Policy, officers, directors and certain employees of Barings must first

obtain pre-clearance from Barings’ compliance department before trading in the Company’s securities. The

Company has also adopted, in its Rule 38a-1 Compliance Manual, restrictions on insider trading (the “Insider

Trading Policy”), which, among other things, governs the purchase, sale, and/or other disposition of the Company’s

securities by the Company’s directors and officers, and which the Company believes are reasonably designed to

promote compliance with insider trading laws, rules and regulations.

Among other things, our Insider Trading Policy prohibits any of our directors and officers (and members of their

immediate families and households and their controlled entities) who are aware of material non-public information,

relating to the Company from, directly, or indirectly through family members or other persons or entities: (1)

engaging in transactions in our securities (except pursuant to Exchange Act Rule 10b5-1), (2) recommending that

others engage in transactions in our securities, (3) disclosing the material, non-public information to persons within

the Company or Barings whose jobs do not require them to have that information, or outside of the Company or

Barings to other persons, including, but not limited to, family, friends, business associates, investors and expert

consulting firms, unless any such disclosure is made in accordance with the Company’s policies regarding the

protection or authorized external disclosure of information regarding the Company, or (4) assisting anyone engaged

in the foregoing activities.

In addition, under the Insider Trading Policy, our directors and officers (and members of their immediate families

and households and their controlled entities) may not engage in any transaction in our securities without first

obtaining pre-clearance of the transaction from the Barings Compliance Department. The Insider Trading Policy

also includes provisions regarding quarterly and event-specific black-out periods, during which our directors and

officers (and members of their immediate families and households and their controlled entities) will not be pre-

cleared under the Insider Trading Policy to transact in our securities, subject to limited exceptions with respect to

quarterly blackout periods.

Our directors and officers are also prohibited under the Insider Trading Policy from engaging in the following

transactions in the Company’s securities: (i) short-term trading (i.e., effectuating opposite-way trades in the same

class of security within six months of each other); (ii) short sales; (iii) buying or selling puts or calls or other

derivative securities on the Company’s securities; (iv) holding Company securities in a margin account or pledging

the Company’s securities as collateral for a loan, subject to certain exceptions upon pre-approval from the Chief

Compliance Officer; and (v) entering into hedging or monetization transactions or similar arrangements with respect

to the Company’s securities. The Insider Trading Policy is filed as an exhibit to the Company’s Annual Report on

Form 10-K for the year ended December 31, 2024.

EXECUTIVE OFFICERS AND INVESTMENT COMMITTEE

The Company’s officers serve at the discretion of the Board of Directors. The biographical information of each of

the Company’s executive officers (in alphabetical order) who is not a director, as well as the Company's Secretary,

who is not an executive officer of the Company, is as follows:

Itzbell Branca, 48, has served as the Company's Chief Compliance Officer since August 2024, and has served as the

Chief Compliance Officer of BPCC and BCIC since August 2024. Ms. Branca is a Senior Director in Sales Practices

Compliance and assists in the development, maintenance, and management of Barings’ compliance programs and

activities relevant to its registered closed-end funds, business development companies, and the Adviser. Ms. Branca

has worked in the industry since 2000 and has extensive experience in compliance, regulatory examinations, broker-

dealer supervision, and business risk management. Prior to joining Barings in 2019, Ms. Branca worked at LPL

Financial in various positions that included Co-Head of Complex Products Supervision. Ms. Branca holds a B.S.

degree in Finance, Marketing and Multinational Business from Florida State University and an M.B.A. from DeVry

University. Ms. Branca holds FINRA licenses series 4, 7, 24, 51, 63, and 66.

Matthew Freund, 36, is the Company’s President and Co-Portfolio Manager and also serves as President of BPCC

and BCIC. Mr. Freund served as a Senior Investment Manager within Barings’ Global Private Finance Group, where

he was responsible for structuring, underwriting, and monitoring North American private finance investments

supporting Barings sponsor clients. Mr. Freund is also a board member for Eclipse Business Credit, a specialty

lender focused on providing asset backed loans. He has worked in the industry since 2009. Prior to joining Barings

in 2015, Mr. Freund worked for US Bank structuring secured loans to support leveraged buyouts for private equity

sponsors. Prior to joining US Bank, Mr. Freund worked in underwriting and analytical roles at Bank of America as

part of corporate and middle market coverage. He has a B.S. in Business Administration degree from Saint Louis

University and is a member of the CFA Institute.

Elizabeth Murray, 47, has served as the Company’s Chief Operating Officer since May 2023 and as its Chief

Financial Officer since April 2023. Ms. Murray also serves as the Chief Operating Officer and Chief Financial

Officer of BCIC and BPCC. Ms. Murray is also a board member for Rocade LLC, a specialty finance company

focused on litigation finance. Ms. Murray previously was the Director of External Report for the Company and

previously served as the Vice President of Financial Reporting at Triangle Capital Corporation prior to the

externalization of the investment management of the Company to Barings LLC. Prior to joining Triangle Capital

Corporation in 2012, Ms. Murray worked in Financial Planning and Analysis for RBC Bank, the U.S. retail banking

division for Royal Bank of Canada. Prior to RBC Bank, Ms. Murray spent seven years at Progress Energy, Inc. and

held various positions in finance, accounting and tax, most recently in Strategy and Financial Planning. Ms. Murray

began her career as a Tax Consultant with PricewaterhouseCoopers. Ms. Murray is a graduate of North Carolina

State University where she obtained a B.S. degree in Accounting and a Master of Accounting degree. She is also a

North Carolina Certified Public Accountant.

Alexandra Pacini, 32, is the Company's Secretary and a Director at Barings LLC. Ms. Pacini also serves as the

Secretary of BCIC, BPCC, Barings Global Short Duration High Yield Fund, Barings Corporate Investors and

Barings Participation Investors.

Ashlee Steinnerd, 43, has served as the Company’s Chief Legal Officer since February 2023. Ms. Steinnerd also

serves as the Head of Regulatory at Barings LLC and as Chief Legal Officer of BPCC, BCIC, Barings Global Short

Duration High Yield Fund, Barings Corporate Investors, and Barings Participation Investors. Ms. Steinnerd has been

a member of the Barings LLC legal team since 2019, advising Barings LLC on a variety of regulatory issues. Prior

to joining Barings LLC, Ms. Steinnerd was Senior Counsel in the Securities and Exchange Commission’s Office of

the Investor Advocate. Ms. Steinnerd held several roles during her tenure at the Securities and Exchange

Commission between 2011 and 2019. Ms. Steinnerd holds a B.S. in Applied International Finance and Applied

International Economics from the American University of Paris, France and a J.D. from Rutgers School of Law.

Investment Committee

The Company is externally managed by Barings LLC, which is registered with the SEC under the Investment

Advisers Act of 1940, as amended. Barings also provides the administrative services necessary for us to operate.

Barings, a wholly-owned subsidiary of MassMutual Life Insurance Company (“MassMutual”), is a leading global

asset management firm, whose primary investment capabilities include fixed income, private credit, real estate,

equity, and alternative investments. Subject to the overall supervision of our Board, a majority of which is made up

of directors that are not “interested persons,” as defined in Section 2(a)(19) of the 1940 Act, of the Company or

Barings, Barings’ Global Private Finance Group (“Barings GPFG”) manages our day-to-day operations, and

provides investment advisory and management services to us. Barings GPFG is part of Barings' $344.1 billion (as of

December 31, 2024) Global Fixed Income Platform that invests in liquid, private and structured credit. Barings

GPFG manages private funds and separately managed accounts, along with multiple public vehicles.

Included in Barings GPFG is Barings North American Private Finance Team (the “U.S. Investment Team”), which

consists of 52 investment professionals (as of December 31, 2024) located in three offices in the United States. The

U.S. Investment Team provides a full set of solutions to the North American middle market, including revolvers,

first and second lien senior secured loans, unitranche structures, mezzanine debt and equity co-investments. The

U.S. Investment Team averages over 20 years of industry experience at the Managing Director and Director level.

Also included in Barings GPFG are its Europe and Asia-Pacific Investment Committees and Private Finance Teams,

which are responsible for our investment origination and portfolio monitoring activities for middle-market

companies in Europe and Asia-Pacific geographies. In addition, Barings believes it has best-in-class support

personnel, including expertise in risk management, legal, accounting, tax, information technology and compliance,

among others. We expect to benefit from the support provided by these personnel in our operations.

The Barings North American Private Finance investment committee (the “Investment Committee”), which is

responsible for our investment origination and portfolio monitoring activities for middle-market companies in North

America, currently consists of seven members: Bryan High, Head of Barings GPFG; Stuart Mathieson, Head of

Europe and Asia-Pacific Private Credit and Capital Solutions; Terry Harris, Head of Portfolio Management for

Barings GPFG; Tyler Gately, Head of North American Private Credit; Matthew Freund, President of the Company,

BCIC and BPCC; Brianne Ptacek, Managing Director; and Bob Shettle, Managing Director. The Investment

Committee averages approximately 23 years of industry experience. A majority of the votes cast at a meeting at

which a majority of the members of the Investment Committee is present is required to approve all investments in

new middle-market companies.

Bryan High, Stuart Mathieson, Terry Harris, Tom Kilpatrick, a member of Barings’ Private Credit and Capital

Solutions Team, and Orla Walsh, Managing Director and member of Barings' Private Credit Team comprise the

Barings GPFG European Investment Committee, and Bryan High, Stuart Mathieson, Terry Harris, Shane Forster,

Managing Director, and Justin Hooley, Managing Director, comprise the Barings GPFG Asia-Pacific Investment

Committee, which committees are responsible for our investment origination and portfolio monitoring activities for

middle-market companies in European and Asia-Pacific geographies, respectively.

Barings believes that the individual and shared experience of these senior team members provides Barings GPFG’s

investment committees with an appropriate balance of shared investment philosophy and difference of background

and opinion.

Portfolio Managers

Matthew Freund and Bryan High serve as portfolio managers to the Company. Mr. Freund's biography and

experience are set forth above, under "Executive Officers and Investment Committee." Mr. High's biography and

experience are as follows:

Bryan High, 44, serves as the Company's Co-Portfolio Manager. Mr. High also serves as Chief Executive Officer of

BCIC and BPCC. Mr. High is Head of Barings GPFG and is responsible for leading a team that originates,

underwrites and manages global private finance investments. Mr. High joined Barings LLC in 2007, and has

extensive experience in public and private credit, distressed debt / special situations, and private equity. Mr. High

currently serves on the investment committees for Capital Solutions, U.S. High Yield and Global Private Structured

Finance. Mr. High is also a member of the Board of Directors for Eclipse Business Capital LLC and Coastal Marina

Holdings, LLC. Prior to joining Barings LLC, Mr. High was an investment banker at a boutique M&A firm where

he advised on middle market transactions. Mr. High also worked at Banc of America Securities LLC in the

restructuring advisory group. Mr. High holds a B.S. in business administration from the University of North

Carolina at Chapel Hill.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The following table sets forth information with respect to the beneficial ownership of the Company's common stock

as of March 7, 2025, the record date, by the Company's directors and executive officers, both individually and as a

group, and by each person known to the Company to beneficially own 5% or more of the outstanding shares of the

Company’s common stock. With respect to persons known to the Company to beneficially own 5% or more of the

outstanding shares of the Company’s common stock, the Company bases such knowledge on beneficial ownership

filings made by the holders with the SEC and other information known to the Company. Other than as set forth in

the table below, none of the Company's directors or executive officers are deemed to beneficially own shares of the

Company's common stock. Beneficial ownership is determined in accordance with the rules of the SEC and includes

voting or investment power with respect to the securities. There is no common stock subject to options or warrants

that are currently exercisable or exercisable within 60 days of March 7, 2025. Percentage of beneficial ownership is

based on 105,408,938 shares of common stock outstanding as of March 7, 2025. Unless otherwise indicated by

footnote, the business address of each person listed below is 300 South Tryon Street, Suite 2500, Charlotte, North

Carolina 28202.


Name of Beneficial Owner	Number of Shares Beneficially Owned(1)	Percentage of Class(2)	Dollar Range of Equity Securities Beneficially Owned(3)
Directors and Executive Officers:
Interested Directors
Eric Lloyd ...................................................................	38,512	*	over $100,000
David Mihalick ...........................................................	20,000	*	over $100,000
Non-Interested Directors
Mark F. Mulhern ........................................................	14,855	*	over $100,000
Thomas W. Okel ........................................................	20,037	*	over $100,000
Jill Olmstead ...............................................................	4,000	*	$10,001 - $50,000
John A. Switzer ..........................................................	6,000	*	$50,001 - $100,000
Robert Knapp	361,034	*	over $100,000
Steve Byers	50,000	*	over $100,000
Valerie Lancaster-Beal	—	*	None
Executive Officers Who Are Not Directors
Itzbell Branca .............................................................	—	*	None
Matthew Freund .........................................................	15,971	*	over $100,000
Elizabeth Murray ........................................................	21,300	*	over $100,000
Ashlee Steinnerd ........................................................	—	*	None
All directors and executive officers as a group (13 persons) ......................................................................	551,709	*	over $100,000
Five-Percent Stockholders: ......................................
Barings LLC ...............................................................	13,639,681	12.9%	over $100,000

* Less than 1.0%

(1)Beneficial ownership in this column has been determined in accordance with Rule 13d-3 of the Exchange Act. Except as

otherwise noted, each beneficial owner of more than five percent of the Company's common stock and each director and

executive officer has sole voting and/or investment power over the shares reported.

(2)Based on a total of 105,408,938 shares issued and outstanding as of March 7, 2025.

(3)Beneficial ownership in this column has been determined in accordance with Rule 16a-1(a)(2) of the Exchange Act. The

dollar range of equity securities beneficially owned is based on a stock price of $9.76 per share as of March 7, 2025.

Dollar ranges are as follows: None, $1 — $10,000, $10,001 — $50,000, $50,001 — $100,000, or over $100,000.

DELINQUENT SECTION 16(A) REPORTS

Section 16(a) of the Exchange Act requires the Company’s officers and directors, and persons who own more than

10% of our common stock, to file reports of securities ownership and changes in such ownership with the SEC.

Officers, directors, and greater than 10% stockholders also are required by SEC rules to furnish the Company with

copies of all Section 16(a) forms they file.

Based solely on the Company’s review of Forms 3, 4 and 5 filed by such persons and information provided by the

Company’s directors and officers, the Company believes that during the year ended December 31, 2024, all Section

16(a) filing requirements applicable to such persons were met in a timely manner, with the following inadvertent

exception: Steve Byers, one of the Company's directors, failed to timely file two Forms 4 with respect to two

transactions in shares of our common stock.

CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS

Related Party Transactions Policy and Procedure

The Company has procedures in place for the review, approval and monitoring of transactions involving the

Company and certain persons related to it. For example, the Company has a code of conduct that generally prohibits

any employee, officer or director of the Company from engaging in any transaction where there is a conflict between

such individual's personal interest and the interests of the Company. Waivers to the code of conduct can generally

only be obtained from the Chief Compliance Officer, a majority of the Board of Directors or the chairperson of the

Audit Committee and are publicly disclosed as required by applicable law and regulations. In addition, the members

of the Audit Committee oversee, on an ongoing basis, and conduct a prior review of all transactions between the

Company and related persons (as defined in Item 404 of Regulation S-K) that are required to be disclosed in the

Company's proxy statement.

As a BDC, the Company is also subject to certain regulatory requirements that restrict the Company's ability to

engage in certain related-party transactions. The Company has separate policies and procedures that have been

adopted to ensure that it does not enter into any such prohibited transactions without seeking necessary approvals,

including prohibited transactions under the 1940 Act.

BDCs generally are prohibited under the 1940 Act from knowingly participating in certain transactions with their

affiliates without the prior approval of their independent directors and, in some cases, of the SEC. Those transactions

include purchases and sales, and so-called “joint” transactions, in which a BDC and one or more of its affiliates

engage in certain types of profit-making activities. Among other things, any person that owns, directly or indirectly,

5.0% or more of a BDC’s outstanding voting securities will be considered an affiliate of the BDC for purposes of the

1940 Act, and a BDC generally is prohibited from engaging in purchases or sales of assets or joint transactions with

such affiliates, absent the prior approval of the BDC’s independent directors or with respect to certain affiliates,

absent an order from the SEC permitting the BDC to do so. For example, without the approval of the SEC, a BDC is

prohibited from engaging in purchases or sales of assets or joint transactions with the BDC’s officers and directors,

and investment adviser, including funds managed by the investment adviser and its affiliates.

BDCs may, however, invest alongside certain related parties or their respective other clients in certain circumstances

where doing so is consistent with current law and SEC staff interpretations. For example, a BDC may invest

alongside such accounts consistent with guidance promulgated by the SEC staff permitting the BDC and such other

accounts to purchase interests in a single class of privately placed securities so long as certain conditions are met,

including that the BDC’s investment adviser, acting on the BDC’s behalf and on behalf of other clients, negotiates

no term other than price. Co-investment with such other accounts is not permitted or appropriate under this guidance

when there is an opportunity to invest in different securities of the same issuer or where the different investments

could be expected to result in a conflict between the BDC’s interests and those of other accounts.

The 1940 Act generally prohibits BDCs from making certain negotiated co-investments with certain affiliates absent

an order from the SEC permitting the BDC to do so. Pursuant to Barings’ existing SEC co-investment exemptive

relief under the 1940 Act (the "Co-Investment Exemptive Relief"), the Company is generally permitted to co-invest

with funds affiliated with Barings if a "required majority" (as defined in Section 57(o) of the 1940 Act) of the

Company's independent directors make certain conclusions in connection with a co-investment transaction,

including that (1) the terms of the transaction, including the consideration to be paid, are reasonable and fair to the

Company and its stockholders and do not involve overreaching in respect of the Company or its stockholders on the

part of any person concerned and (2) the transaction is consistent with the interests of the Company's stockholders

and is consistent with the Company's investment objective and strategies. Co-investments made under the Co-

Investment Exemptive Relief are subject to compliance with the conditions and other requirements contained in the

Co-Investment Exemptive Relief, which could limit the Company’s ability to participate in a co-investment

transaction.

The Company’s executive officers and the members of the Investment Committee, as well as the other principals of

Barings, manage other funds affiliated with Barings, including BCIC and BPCC and other closed-end investment

companies. In addition, Barings' investment team has responsibilities for managing U.S. and global middle-market

debt investments for certain other investment funds and accounts. Accordingly, they have obligations to investors in

those entities, the fulfillment of which may not be in the best interests of, or may be adverse to the interests of, the

Company or its stockholders. In addition, certain of the other funds and accounts managed by Barings may provide

for higher management or incentive fees, greater expense reimbursements or overhead allocations, or permit Barings

and its affiliates to receive higher origination and other transaction fees, all of which may contribute to this conflict

of interest and create an incentive for Barings to favor such other funds or accounts. Although the professional staff

of Barings will devote as much time to the Company’s management as appropriate to enable Barings to perform its

duties in accordance with the Advisory Agreement, the investment professionals of Barings may have conflicts in

allocating their time and services among the Company, on the one hand, and the other investment vehicles managed

by Barings or one or more of its affiliates on the other hand.

Barings may face conflicts in allocating investment opportunities between the Company and affiliated investment

vehicles that have overlapping investment objectives with ours, including BCIC and BPCC. In addition, the

Company may not be made aware of and/or be given the opportunity to participate in certain investments made by

investment funds which are managed by advisers affiliated with Barings and do not participate in the co-investment

program described in the Co-Investment Exemptive Relief. In situations where co-investment with other affiliated

funds or accounts is not permitted or appropriate, Barings will need to decide which account will proceed with the

investment in accordance with its allocation policies and procedures. Although Barings will endeavor to allocate

investment opportunities in a fair and equitable manner in accordance with its allocation policies and procedures, it

is possible that, in the future, the Company may not be given the opportunity to participate in investments made by

investment funds managed by Barings or an investment manager affiliated with Barings if such investment is

prohibited by the Co-Investment Exemptive Relief or the 1940 Act. These restrictions, and similar restrictions that

limit the Company's ability to transact business with its officers or directors or their affiliates, including funds

managed by Barings, may limit the scope of investment opportunities that would otherwise be available to the

Company.

Advisory Agreement

The Company is party to the Advisory Agreement with Barings, in which certain directors and officers of the

Company and members of the Investment Committee may have indirect ownership and pecuniary interests. For the

year ended December 31, 2024, the base management fee determined in accordance with the terms of the Advisory

Agreement was approximately $32.4 million. For the year ended December 31, 2024, the income-based fee

determined in accordance with the terms of the Advisory Agreement was approximately $23.8 million.

Administration Agreement

Pursuant to the terms of the Administration Agreement between Barings and the Company, Barings provides the

Company with certain administrative and other services necessary to conduct the Company's day-to-day operations.

The Company reimburses Barings, in its capacity as administrator, for the costs and expenses incurred and billed to

the Company by Barings in performing its obligations and providing personnel and facilities under the

Administration Agreement, or such lesser amount as may be agreed to by the Company and Barings from time to

time. If the Company and Barings agree to a reimbursement amount for any period which is less than the full

amount otherwise permitted under the Administration Agreement, then Barings will not be entitled to recoup any

difference thereof in any subsequent period or otherwise. See "Compensation Discussion" above for more

information. For the fiscal year ended December 31, 2024, the Company incurred and was invoiced by Barings for

expenses of approximately $2.0 million under the terms of the Administration Agreement.

Barings Credit Support Agreements

In connection with the Company’s merger with MVC Capital, Inc., in December 2020, the Company entered into a

Credit Support Agreement (the “MVC Capital Credit Support Agreement”) with Barings, pursuant to which Barings

has agreed to provide credit support to the Company in the amount of up to $23.0 million relating to the net

cumulative realized and unrealized losses on the acquired MVC Capital, Inc. investment portfolio over a 10-year

period. The MVC Capital Credit Support Agreement is intended to give stockholders of the combined company

following the merger of the Company and MVC Capital, Inc. downside protection from net cumulative realized and

unrealized losses on the acquired MVC Capital, Inc. portfolio and insulate the combined company’s stockholders

from potential value volatility and losses in MVC Capital, Inc.’s portfolio following the closing of the merger. There

is no fee or other payment by the Company to Barings or any of its affiliates in connection with the MVC Capital

Credit Support Agreement. Any cash payment from Barings to the Company under the MVC Capital Credit Support

Agreement will be excluded from the incentive fee calculations under the Advisory Agreement.

In connection with the Company’s merger with Sierra Income Corporation, in February 2022, the Company entered

into a Credit Support Agreement (the “SIC Credit Support Agreement”) with Barings, pursuant to which Barings has

agreed to provide credit support to the Company in the amount of up to $100.0 million relating to the net cumulative

realized and unrealized losses on the acquired Sierra Income Corporation investment portfolio over a 10-year period.

The SIC Credit Support Agreement is intended to give stockholders of the combined company following the merger

of the Company and Sierra Income Corporation downside protection from net cumulative realized and unrealized

losses on the acquired Sierra Income Corporation portfolio and insulate the combined company’s stockholders from

potential value volatility and losses in Sierra Income Corporation’s portfolio following the closing of the merger.

There is no fee or other payment by the Company to Barings or any of its affiliates in connection with the SIC Credit

Support Agreement. Any cash payment from Barings to the Company under the SIC Credit Support Agreement will

be excluded from the incentive fee calculations under the Advisory Agreement.

August 2020 Note Purchase Agreement

On August 3, 2020, the Company entered into a Note Purchase Agreement (the “August 2020 NPA”) with

Massachusetts Mutual Life Insurance Company, which wholly-owns Barings, governing the issuance of (1)

$50.0 million in aggregate principal amount of Series A senior unsecured notes due August 2025 (the “Series A

Notes”) with a fixed interest rate of 4.66% per year, and (2) up to $50.0 million in aggregate principal amount of

additional senior unsecured notes due August 2025 with a fixed interest rate per year to be determined (the

“Additional Notes” and, collectively with the Series A Notes, the “August 2025 Notes”), in each case, to qualified

institutional investors in a private placement. The Company issued an aggregate principal amount of $25.0 million

of the Series A Notes on September 24, 2020 and an aggregate principal amount of $25.0 million of the Series A

Notes on September 29, 2020, both of which will mature on August 4, 2025 unless redeemed, purchased or prepaid

prior to such date in accordance with their terms. Interest on the August 2025 Notes is due semiannually in March

and September of each year, beginning in March 2021. In addition, the Company is obligated to offer to repay the

August 2025 Notes at par (plus accrued and unpaid interest to, but not including, the date of prepayment) if certain

change in control events occur. Subject to the terms of the August 2020 NPA, the Company may redeem the August

2025 Notes in whole or in part at any time or from time to time at the Company’s option at par plus accrued interest

to the prepayment date and, if redeemed on or before November 3, 2024, a make-whole premium. The August 2025

Notes are guaranteed by certain of the Company’s subsidiaries and are the Company’s general unsecured obligations

that rank pari passu with all outstanding and future unsecured unsubordinated indebtedness issued by the Company.

Upon the occurrence of an event of default, the holders of at least 66-2/3% in principal amount of the August 2025

Notes at the time outstanding may declare all August 2025 Notes then outstanding to be immediately due and

payable.

The Company's permitted issuance period for the Additional Notes under the August 2020 NPA expired on February

3, 2022, prior to which date the Company had issued no Additional Notes.

November 2020 Note Purchase Agreement

On November 4, 2020, the Company entered into a Note Purchase Agreement (the “November 2020 NPA”)

governing the issuance of (1) $62.5 million in aggregate principal amount of Series B senior unsecured notes due

November 2025 (the “Series B Notes”) with a fixed interest rate of 4.25% per year and (2) $112.5 million in

aggregate principal amount of Series C senior unsecured notes due November 2027 (the “Series C Notes” and,

collectively with the Series B Notes, the “November Notes”) with a fixed interest rate of 4.75% per year, in each

case, to qualified institutional investors in a private placement. Each stated interest rate is subject to a step up of (x)

0.75% per year, to the extent the applicable November Notes do not satisfy certain investment grade conditions and/

or (y) 1.50% per year, to the extent the ratio of the Company’s secured debt to total assets exceeds specified

thresholds, measured as of each fiscal quarter end. The November Notes were delivered and paid for on November

5, 2020.

The Series B Notes will mature on November 4, 2025, and the Series C Notes will mature on November 4, 2027

unless redeemed, purchased or prepaid prior to such date by the Company in accordance with their terms. Interest on

the November Notes is due semiannually in May and November, beginning in May 2021. In addition, the Company

is obligated to offer to repay the November Notes at par (plus accrued and unpaid interest to, but not including, the

date of prepayment) if certain change in control events occur. Subject to the terms of the November 2020 NPA, the

Company may redeem the Series B Notes and the Series C Notes in whole or in part at any time or from time to time

at the Company’s option at par plus accrued interest to the prepayment date and, if redeemed on or before May 4,

2025, with respect to the Series B Notes, or on or before May 4, 2027, with respect to the Series C Notes, a make-

whole premium. The November Notes are guaranteed by certain of the Company’s subsidiaries, and are the

Company's general unsecured obligations that rank pari passu with all outstanding and future unsecured

unsubordinated indebtedness issued by the Company. Upon the occurrence of an event of default, the holders of at

least 66-2/3% in principal amount of the November Notes at the time outstanding may declare all November Notes

then outstanding to be immediately due and payable.

Barings’ parent company, Massachusetts Mutual Life Insurance Company, holds $25.0 million in aggregate

principal amount of the Series B Notes.

February 2021 Note Purchase Agreement

On February 25, 2021, the Company entered into a Note Purchase Agreement (the “February 2021 NPA”) governing

the issuance of (1) $80.0 million in aggregate principal amount of Series D senior unsecured notes due February 26,

2026 (the “Series D Notes”) with a fixed interest rate of 3.41% per year and (2) $70.0 million in aggregate principal

amount of Series E senior unsecured notes due February 26, 2028 (the “Series E Notes” and, collectively with the

Series D Notes, the “February Notes”) with a fixed interest rate of 4.06% per year, in each case, to qualified

institutional investors in a private placement. Each stated interest rate is subject to a step up of (x) 0.75% per year, to

the extent the applicable February Notes do not satisfy certain investment grade rating conditions and/or (y) 1.50%

per year, to the extent the ratio of the Company’s secured debt to total assets exceeds specified thresholds, measured

as of each fiscal quarter end. The February Notes were delivered and paid for on February 26, 2021.

The Series D Notes will mature on February 26, 2026, and the Series E Notes will mature on February 26, 2028

unless redeemed, purchased or prepaid prior to such date by the Company in accordance with the terms of the

February 2021 NPA. Interest on the February Notes is due semiannually in February and August of each year,

beginning in August 2021. In addition, the Company is obligated to offer to repay the February Notes at par (plus

accrued and unpaid interest to, but not including, the date of prepayment) if certain change in control events occur.

Subject to the terms of the February 2021 NPA, the Company may redeem the Series D Notes and the Series E

Notes in whole or in part at any time or from time to time at the Company’s option at par plus accrued interest to the

prepayment date and, if redeemed on or before August 26, 2025, with respect to the Series D Notes, or on or before

August 26, 2027, with respect to the Series E Notes, a make-whole premium. The February Notes are guaranteed by

certain of the Company’s subsidiaries, and are the Company's general unsecured obligations that rank pari passu

with all outstanding and future unsecured unsubordinated indebtedness issued by the Company. Upon the

occurrence of certain events of default, the holders of at least 66-2/3% in principal amount of the February Notes at

the time outstanding may declare all February Notes then outstanding to be immediately due and payable.

Barings’ parent company, Massachusetts Mutual Life Insurance Company, holds $25.0 million in aggregate

principal amount of the Series D Notes.

November 2026 Notes Indenture

On November 23, 2021, the Company and U.S. Bank Trust Company, National Association (the “Trustee”) entered

into an Indenture (the “Base Indenture”) and a First Supplemental Indenture (the “First Supplemental Indenture”

and, together with the Base Indenture, the “November 2026 Notes Indenture”). The First Supplemental Indenture

relates to the Company’s issuance of $350.0 million aggregate principal amount of its 3.300% notes due 2026 (the

“November 2026 Notes”).

The November 2026 Notes will mature on November 23, 2026 and may be redeemed in whole or in part at the

Company’s option at any time or from time to time at the redemption prices set forth in the November 2026 Notes

Indenture. The November 2026 Notes bear interest at a rate of 3.300% per year payable semi-annually in May and

November of each year, commencing in May 2022. The November 2026 Notes are general unsecured obligations of

the Company that rank senior in right of payment to all of the Company’s existing and future indebtedness that is

expressly subordinated in right of payment to the November 2026 Notes, rank pari passu with all existing and future

unsecured unsubordinated indebtedness issued by the Company, rank effectively junior to any of the Company’s

secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of

the assets securing such indebtedness, and rank structurally junior to all existing and future indebtedness (including

trade payables) incurred by the Company’s subsidiaries, financing vehicles or similar facilities.

The November 2026 Notes Indenture contains certain covenants, including covenants requiring the Company to

comply with the asset coverage requirements of Section 18(a)(1)(A) as modified by Sections 61(a)(1) and (2) of the

1940 Act, whether or not it is subject to those requirements, and to provide financial information to the holders of

the November 2026 Notes and the Trustee if the Company is no longer subject to the reporting requirements under

the Exchange Act. These covenants are subject to important limitations and exceptions that are described in the

November 2026 Notes Indenture.

In addition, on the occurrence of a “change of control repurchase event,” as defined in the November 2026 Notes

Indenture, the Company will generally be required to make an offer to purchase the outstanding November 2026

Notes at a price equal to 100% of the principal amount of such November 2026 Notes plus accrued and unpaid

interest to the repurchase date.

The November 2026 Notes were offered to qualified institutional buyers pursuant to Rule 144A under the Securities

Act and to certain non-U.S. persons outside the United States pursuant to Regulation S under the Securities Act.

Concurrent with the closing of November 2026 Notes offering, the Company entered into a registration rights

agreement for the benefit of the purchasers of the November 2026 Notes. Pursuant to the terms of this registration

rights agreement, the Company filed a registration statement on Form N-14 with the SEC, which was subsequently

declared effective, to permit electing holders of the November 2026 Notes to exchange all of their outstanding

restricted November 2026 Notes for an equal aggregate principal amount of new November 2026 Notes (the

“Exchange Notes”). The Exchange Notes have terms substantially identical to the terms of the November 2026

Notes, except that the Exchange Notes are registered under the Securities Act, and certain transfer restrictions,

registration rights, and additional interest provisions relating to the November 2026 Notes do not apply to the

Exchange Notes.

Barings’ parent company, Massachusetts Mutual Life Insurance Company, and certain of its subsidiaries collectively

hold $50.0 million in aggregate principal amount of the November 2026 Notes.

February 2029 Notes Indenture

On February 12, 2024, the Company issued $300 million in aggregate principal amount of 7.000% senior unsecured

notes due 2029 (the “February 2029 Notes”) under a Second Supplemental Indenture, dated February 12, 2024,

between the Company and the Trustee (the “Second Supplemental Indenture” and, together with the Base Indenture,

the “February 2029 Notes Indenture”) to the Base Indenture.

The February 2029 Notes will mature on February 15, 2029 and may be redeemed in whole or in part at the

Company’s option at any time or from time to time at the redemption prices set forth in the February 2029 Notes

Indenture. The February 2029 Notes bear interest at a rate of 7.000% per year payable semi-annually in February

and August of each year, commencing in August 2024. The February 2029 Notes are general unsecured obligations

of the Company that rank senior in right of payment to all of the Company’s existing and future indebtedness that is

expressly subordinated in right of payment to the February 2029 Notes, rank pari passu with all existing and future

unsecured unsubordinated indebtedness issued by the Company, rank effectively junior to any of the Company’s

secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of

the assets securing such indebtedness, and rank structurally junior to all existing and future indebtedness (including

trade payables) incurred by the Company’s subsidiaries, financing vehicles or similar facilities.

The February 2029 Notes Indenture contains certain covenants, including covenants requiring the Company to

comply with the asset coverage requirements of Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the

1940 Act, whether or not it is subject to those requirements (but giving effect to exemptive relief granted to the

Company by the SEC), and to provide financial information to the holders of the February 2029 Notes and the

Trustee if the Company is no longer subject to the reporting requirements under the Exchange Act. These covenants

are subject to important limitations and exceptions that are described in the February 2029 Notes Indenture.

In addition, on the occurrence of a “change of control repurchase event,” as defined in the February 2029 Notes

Indenture, the Company may be required by the holders of the February 2029 Notes to make an offer to purchase the

outstanding February 2029 Notes at a price equal to 100% of the principal amount of such February 2029 Notes plus

accrued and unpaid interest to the repurchase date.

Barings’ parent company, Massachusetts Mutual Life Insurance Company, holds $25.0 million in aggregate

principal amount of the February 2029 Notes.

INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Audit Committee and Board of Directors, including a majority of the independent directors, have selected

KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending

December 31, 2025. KPMG LLP also will serve as the independent auditors for all of the Company’s wholly-owned

subsidiaries and its joint ventures, Jocassee Partners LLC, Thompson Rivers LLC, Waccamaw River LLC, and

Sierra Senior Loan Strategy JV I LLC.

We expect representatives of KPMG LLP will be present at the Annual Meeting and will have an opportunity to

make a statement if they desire to do so and to respond to appropriate questions.

Independent Registered Public Accounting Firm's Fees

Fees Paid to Independent Registered Public Accounting Firm

The following table provides information regarding the fees billed by KPMG LLP for work performed for the fiscal

years ended December 31, 2024 and 2023, or attributable to the audit of the Company's 2024 or 2023 financial

statements, including out-of-pocket expenses:


	Fiscal Year Ended December 31, 2024	Fiscal Year Ended December 31, 2023
Audit Fees ................................	$1,371,567	$1,378,403
Audit Related Fees ...................	—	—
Tax Fees ...................................	163,925	272,100
Other Fees ................................	—	—
TOTAL FEES .........................	$1,535,492	$1,650,503

During the fiscal years ended December 31, 2024 and 2023, KPMG LLP billed aggregate non-audit fees of

$301,036 (comprised of $137,111 related to Barings LLC and $163,925 related to Barings BDC, Inc.) and $315,169

(comprised of $43,069 related to Barings LLC and $272,100 related to Barings BDC, Inc.), respectively, for services

rendered to the Company and for services rendered to Barings LLC.

Audit Fees. Audit fees include fees for services that normally would be provided by the accountant in connection

with statutory and regulatory filings or engagements and that generally only the independent accountant can provide.

In addition to fees for the audit of the Company's annual financial statements, the audit of the effectiveness of the

Company's internal control over financial reporting and the review of the Company's quarterly financial statements

in accordance with generally accepted auditing standards, this category contains fees for comfort letters, statutory

audits, consents, and assistance with and review of documents filed with the SEC.

Audit Related Fees. Audit related fees are assurance related services that traditionally are performed by the

independent accountant, such as attest services that are not required by statute or regulation.

Tax Fees. Tax fees include corporate and subsidiary compliance and consulting.

All Other Fees. Fees for other services would include fees for products and services other than the services reported

above, including any non-audit fees.

Pre-Approval Policies and Procedures

The Audit Committee has established, and the Board of Directors has approved, a pre-approval policy that describes

the permitted audit, audit-related, tax and other services to be provided by the Company’s independent registered

accounting firm. The policy requires that the Audit Committee pre-approve the audit and non-audit services

performed by the independent registered accounting firm in order to assure that the provision of such service does

not impair the firm’s independence.

Any requests for audit, audit-related, tax and other services that have not received general pre-approval must be

submitted to the Audit Committee for specific pre-approval, irrespective of the amount, and cannot commence until

such approval has been granted. Normally, pre-approval is provided at regularly scheduled meetings of the Audit

Committee. However, the Audit Committee may delegate pre-approval authority to one or more of its members. The

member or members to whom such authority is delegated shall report any pre-approval decisions to the Audit

Committee at a subsequent meeting. The Audit Committee does not delegate its responsibilities to pre-approve

services performed by the independent registered accounting firm to management. During 2024 and 2023, 100% of

the Company’s audit fees, audit-related fees, tax fees and fees for other services provided by the Company's

independent registered public accounting firm were pre-approved by the Audit Committee.

1 Reflects the membership of the Audit Committee as of the date of the Audit Committee's recommendations and approval

referenced in this Audit Committee report.

AUDIT COMMITTEE REPORT

The Audit Committee assists the Board of Directors in its oversight of the Company’s financial reporting process

and implementation and maintenance of effective controls to prevent, deter and detect fraud by management. In

addition, the Audit Committee is directly responsible for the appointment, compensation and oversight of the

Company’s independent registered public accounting firm. Each of the members of the Audit Committee qualifies as

an “independent” director in accordance with NYSE listing standards, SEC rules and the Company’s corporate

governance guidelines.

In overseeing the preparation of the Company’s financial statements, the Audit Committee met with both

management and KPMG LLP, the Company’s independent registered public accounting firm for the fiscal year

ended December 31, 2024, to review and discuss the audited financial statements prior to their issuance and to

discuss significant accounting issues. Management advised the Audit Committee that all financial statements were

prepared in accordance with generally accepted accounting principles, and the Audit Committee discussed the

financial statements with both management and KPMG LLP.

The Audit Committee also is responsible for assisting the Board of Directors in the oversight of the qualification,

independence and performance of the Company’s independent auditor. In connection with the audit of the

Company’s financial statements for the fiscal year ended December 31, 2024, the Audit Committee regularly met in

separate, executive sessions with certain members of senior management and KPMG LLP. The Audit Committee

has discussed with KPMG LLP the matters required to be discussed by the applicable requirements of the Public

Company Accounting Oversight Board, or PCAOB, and the SEC. The Audit Committee has received from KPMG

LLP the written disclosures and the letter required by applicable requirements of the PCAOB regarding KPMG

LLP’s communications with the Audit Committee concerning independence and has discussed with KPMG LLP its

independence. In addition, the Audit Committee has considered whether the provision of non-audit services, and the

fees charged for such services, by KPMG LLP are compatible with KPMG LLP maintaining its independence from

the Company.

Based upon the review and discussions referred to above, the Audit Committee recommended to the Company’s

Board of Directors that the Company’s audited consolidated financial statements be included in the Company’s

Annual Report on Form 10-K for the fiscal year ended December 31, 2024. In addition, the Audit Committee has

selected, and recommended to the Board of Directors that it approve the appointment of KPMG LLP as the

Company’s independent registered public accounting firm for the year ending December 31, 2025.

THE AUDIT COMMITTEE1

Mark F. Mulhern, Chair

Thomas W. Okel

Robert Knapp

Jill Olmstead

John A. Switzer

Steve Byers

Valerie Lancaster-Beal

The foregoing report shall not be deemed incorporated by reference by any general statement incorporating by

reference this Proxy Statement into any filing under the Securities Act of 1933, as amended (the “Securities Act”),

or the Exchange Act, except to the extent that the Company specifically incorporates this Audit Committee report by

reference, and shall not otherwise be deemed filed under such Securities Act and/or Exchange Act.

PROPOSAL NO. 2

APPROVAL TO SELL SHARES OF COMMON STOCK BELOW NET ASSET VALUE (BOOK VALUE)

The Company is a closed-end investment company that has elected to be treated as a BDC under the 1940 Act. The

1940 Act generally prohibits the Company, as a BDC, from issuing and selling shares of its common stock at a price

below the then-current net asset value (i.e., book value) per share of such stock, with certain exceptions. One such

exception would permit the Company to issue and sell shares of its common stock at a price below net asset value

per share at the time of sale if the Company’s stockholders have approved a sale below net asset value per share

within the one-year period immediately prior to any such sale, provided that the Board of Directors also makes

certain determinations prior to any such sale.

Pursuant to this provision, the Company is seeking the approval of its stockholders so that it may, in one or more

public or private offerings of its common stock, issue and sell shares of its common stock at a price below its then-

current net asset value per share in one or more offerings, subject to certain conditions discussed below. It should be

noted that the maximum number of shares that the Company could issue and sell at a per share price below net asset

value per share pursuant to this authority would be limited to 30% of its then-outstanding common stock. If

approved, the authorization would be effective for a period expiring on the first anniversary of the date of the

stockholders’ approval of this proposal and would permit the Company to engage in such transactions at various

times within that period, subject to further approval from the Board of Directors.

Generally, equity securities sold in public securities offerings are priced based on public market prices quoted on

exchanges such as NYSE, rather than net asset value, or book value, per share. Since the Company’s IPO, the

Company’s common stock has traded both above and below its net asset value per share. At each of the Company’s

Annual Meetings of Stockholders from 2008 to 2017, and at its 2020, 2021, 2022, and 2023 Annual Meetings of

Stockholders, the Company requested and received approval from its stockholders to sell its stock at a price per

share below net asset value under certain circumstances.

Similar to prior years, the Company is seeking the approval of a majority of its stockholders of record to offer and

sell shares of its common stock at prices that, net of underwriting discount or commissions, may be less than net

asset value per share in one or more offerings. This stockholder approval would permit the Company to issue and

sell shares of its common stock in accordance with pricing standards that market conditions generally require, and

would also assure stockholders that the number of shares issued and sold pursuant to such authority does not exceed

30% of the Company’s then-outstanding common stock immediately prior to each such offering. If stockholders

approve this proposal, the Company should have greater flexibility in taking advantage of changing market and

financial conditions in connection with an equity offering. Of the Company’s ten underwritten follow-on equity

offerings completed since its IPO, only two were priced below the then-current net asset value per share (both

during 2009).

Reasons to Offer Common Stock Below Net Asset Value

Market Conditions Have Created, and May in the Future Create, Attractive Investment and Acquisition

Opportunities

From time to time, capital markets may experience periods of disruption and instability. The market has recently

experienced such a period of instability due to the effects of inflation and elevated interest rates. Periods of market

disruption and instability may recur and adversely affect the Company’s access to sufficient debt and equity capital.

It may be advantageous to seek to raise additional equity capital in a public offering or private placements, which

would be greatly aided by the flexibility of being able to offer shares of common stock at a price below current

NAV. Further, debt capital that will be available, if any, may be at a higher cost and on less favorable terms and

conditions. This access to equity capital will allow the Company to better negotiate with its lenders and avoid the

Company from being a forced seller of assets in this current marketplace. We also believe it will preserve financial

flexibility during these uncertain times for other purposes, such as providing liquidity to troubled portfolio

companies by participating in capital restructurings. In addition, the Company believes that favorable investment

opportunities to invest at attractive risk-adjusted returns, including opportunities to make acquisitions of other

companies or investment portfolios at attractive values, may be created during these periods of disruption and

volatility.

Stockholder approval of the proposal to sell shares of the Company’s common stock at a price below its then-current

net asset value per share, subject to the conditions set forth in this proposal, would provide the Company with the

flexibility to invest in such attractive investment opportunities, which typically need to be made expeditiously.

Trading History

Since the Company’s IPO in 2007, the Company’s common stock has traded both at a premium and at a discount in

relation to its net asset value, which is the equivalent of “book value,” rather than market or publicly traded value.

As of the record date of March 7, 2025, the Company's common stock traded at a discount to net asset value per

share. The possibility that shares of the Company’s common stock will continue to trade at a discount from net asset

value or trade at premiums that are unsustainable over the long-term are separate and distinct from the risk that the

Company’s net asset value will decrease. It is not possible to predict whether any shares of the Company’s common

stock issued in the future will trade at, above, or below net asset value.

The following table, reflecting the public trading history of our common stock since January 1, 2022 lists the high

and low closing sales prices for our common stock, and such closing sales prices as percentages of the net asset

values per share for the relevant periods. On March 7, 2025, the record date, the last reported closing sale price of

our common stock on the NYSE was $9.76. Net asset value per share in the table below is determined as of the last

day in the relevant quarter and therefore may not reflect the net asset value per share on the date of the high and low

closing sales prices. The net asset values shown are based on outstanding shares at the end of each period.


	Net Asset Value	Closing Sales Price		Premium (Discount) of High Closing Sales Price to Net Asset Value	Premium (Discount) of Low Closing Sales Price to Net Asset Value
	Net Asset Value	High	Low
Year ended December 31, 2022
First Quarter ..............................................	$11.86	$11.20	$10.07	(5.6)%	(15.1)%
Second Quarter ..........................................	$11.41	$10.90	$9.24	(4.5)%	(19.0)%
Third Quarter .............................................	$11.28	$10.41	$8.32	(7.7)%	(26.2)%
Fourth Quarter	$11.05	$9.26	$8.06	(16.2)%	(27.1)%
Year ended December 31, 2023
First Quarter ..............................................	$11.17	$8.95	$8.22	(19.9)%	(26.4)%
Second Quarter ..........................................	$11.34	$8.01	$7.19	(29.4)%	(36.6)%
Third Quarter .............................................	$11.25	$9.34	$7.65	(17.0)%	(32.0)%
Fourth Quarter ...........................................	$11.28	$9.39	$8.58	(16.8)%	(23.9)%
Year ended December 31, 2024
First Quarter ..............................................	$11.44	$9.88	$8.70	(13.6)%	(24.0)%
Second Quarter ..........................................	$11.36	$10.18	$9.13	(10.4)%	(19.6)%
Third Quarter .............................................	$11.32	$10.19	$9.28	(10.0)%	(18.0)%
Fourth Quarter ...........................................	$11.29	$10.33	$9.27	(8.5)%	(17.9)%
Year ending December 31, 2025 ..............
First Quarter (Through March 7, 2025) ....	*	$10.78	$9.36	*	*

* Net asset value has not yet been calculated for this period.

Greater Investment Opportunities Due to Larger Capital Resources

The additional capital raised through an offering of the Company’s common stock may help the Company generate

additional deal flow. With more capital to make investments, the Company could be a more meaningful capital

provider and such additional capital would allow it to compete more effectively for high quality investment

opportunities. Such investment opportunities may be funded with proceeds of an offering of shares of the

Company’s common stock.

Status as a BDC and RIC and Maintaining a Favorable Debt-to-Equity Ratio

As a BDC and a regulated investment company, or RIC, for tax purposes, the Company is dependent on its ability to

raise capital through the issuance of its common stock. RICs generally must distribute substantially all of their

earnings to stockholders as dividends in order to achieve pass-through tax treatment, which prevents the Company

from retaining any meaningful amount of earnings to support operations, which may include making new

investments (including investments in existing portfolio companies). Further, under the 1940 Act, the Company

must meet a debt-to-equity ratio of less than approximately 2:1 in order to incur debt or issue senior securities.

Therefore, to continue to build the Company’s investment portfolio, the Company endeavors to maintain consistent

access to capital through the public and private debt markets and the public equity markets enabling it to take

advantage of investment opportunities as they arise.

Exceeding the approximate 2:1 debt-to-equity ratio could have severe negative consequences for a BDC, including

the inability to pay dividends, breach of applicable debt covenants and failure to qualify for tax treatment as a RIC.

Although the Company does not currently expect that it will exceed this debt-to-equity ratio, the markets it operates

in and the general economy may be volatile and uncertain. Even though the underlying performance of a particular

portfolio company may not indicate an impairment or its inability to repay all principal and interest in full, volatility

in the capital markets may negatively impact the valuations of investments and create unrealized losses on certain

investments. Any such write-downs in value, as well as unrealized losses based on the underlying performance of

the Company’s portfolio companies, if any, will negatively impact stockholders’ equity and the resulting debt-to-

equity ratio. Issuing additional equity would allow the Company to realign its debt-to-equity ratio and take steps to

avoid these negative consequences. In addition to meeting legal requirements applicable to BDCs, having a more

favorable debt-to-equity ratio would also generally strengthen the Company’s balance sheet and give it more

flexibility to fully execute its business strategy.

Summary

The Board of Directors believes it is desirable to have the flexibility to issue shares of the Company’s common stock

at a price below the Company’s then-current net asset value per share in certain instances when it is in the best

interests of the Company and its stockholders. This would, among other things, provide access to capital markets to

pursue attractive investment and acquisition opportunities during periods of volatility, improve capital resources to

enable the Company to compete more effectively for high quality investment opportunities and add financial

flexibility to comply with regulatory requirements and any applicable debt facility covenants, including the 2:1 debt-

to-equity ratio limit under the 1940 Act. It could also minimize the likelihood that the Company would be required

to sell assets that the Company would not otherwise sell, which sales could occur at times and at prices that are

disadvantageous to the Company.

The final terms of any sale of the Company’s common stock at a price below the then-current net asset value per

share will be determined by the Board of Directors in connection with such issuance, and the shares of common

stock will not include preemptive rights. Any transaction in which the Company issues such shares of common

stock, including the nature and amount of consideration that would be received by the Company at the time of

issuance and the use of any proceeds therefrom, will be reviewed and approved by the Board of Directors at the time

of issuance. If this proposal is approved, no further authorization from the stockholders will be solicited prior to any

such issuance in accordance with the terms of this proposal. If approved, the authorization would be effective for a

period expiring on the first anniversary of the date of the stockholders’ approval of this proposal and would permit

the Company to engage in such transactions at various times within that period, subject to further approval from the

Board of Directors.

Conditions to Sales Below Net Asset Value

Stockholder approval is a condition that must be satisfied prior to any sales of the Company’s common stock at a

price below the then-current net asset value per share, and the Company is seeking such approval in this proposal. If

this proposal is approved by the Company’s stockholders, the Company would not issue and sell its common stock

at a price below its per share net asset value unless the number of shares issued and sold pursuant to such authority

does not exceed 30% of the Company’s then-outstanding common stock immediately prior to each such offering. To

the extent the Company issues and sells shares of its common stock, regardless of the price at which such shares are

sold, the Company’s market capitalization and the amount of its publicly tradable common stock will increase, thus

affording all common stockholders potentially greater liquidity in the market for the Company’s shares.

In addition, if this proposal is approved, the Company will issue and sell shares of its common stock at a price below

net asset value per share only if the following conditions are met:

▪a majority of the Company’s directors who have no financial interest in the issuance and sale and a

majority of such directors who are not interested persons of the Company have determined that any such

sale would be in the best interests of the Company and its stockholders; and

▪a majority of the Company’s directors who have no financial interest in the issuance and sale, and a

majority of such directors who are not interested persons of the Company, in consultation with the

underwriter or underwriters of the offering if it is to be underwritten, and as of a time immediately prior to

the first solicitation by or on behalf of the Company of firm commitments to purchase such securities or

immediately prior to the issuance of such securities, have determined in good faith that the price at which

such securities are to be issued and sold is not less than a price which closely approximates the market

value of those securities, less any distributing commission or discount.

In determining whether or not to sell additional shares of the Company’s common stock at a price below the net

asset value per share, the Board of Directors will be obligated to act in the best interests of the Company and its

stockholders.

Key Stockholder Considerations

Before voting on this proposal or giving proxies with regard to this matter, stockholders should consider the dilutive

effect on the net asset value per outstanding share of common stock of the issuance of shares of the Company’s

common stock at less than net asset value per share. Any sale of common stock at a price below net asset value

would result in an immediate dilution to existing common stockholders. Since under this proposal shares of the

Company’s common stock could be issued at a price that is substantially below the net asset value per share, the

dilution could be substantial. This dilution would include reduction in the net asset value per share as a result of the

issuance of shares at a price below the net asset value per share and a proportionately greater decrease in a

stockholder’s interest in the earnings and assets of the Company and voting interest in the Company than the

increase in the assets of the Company resulting from such issuance. If this Proposal No. 2 is approved, the Board of

Directors of the Company may, consistent with its fiduciary duties, approve the sale of the Company’s common

stock at any discount to its then-current net asset value per share; however, the Board of Directors will consider the

potential dilutive effect of the issuance of shares of common stock at a price below the net asset value per share

when considering whether to authorize any such issuance and will act in the best interests of the Company and its

stockholders in doing so. It should be noted that the maximum number of shares that the Company could issue and

sell at a per share price below net asset value per share pursuant to this authority would be limited to 30% of the

Company’s then-outstanding common stock immediately prior to each such offering.

The 1940 Act establishes a connection between common share sale price and net asset value because, when shares

of common stock are sold at a sale price below net asset value per share, the resulting increase in the number of

outstanding shares is not accompanied by a proportionate increase in the net assets of the issuer. Further, if current

stockholders of the Company do not purchase any shares to maintain their percentage interest, regardless of whether

such offering is above or below the then-current net asset value, their voting power will be diluted. For an

illustration of the potential dilutive effect of an offering of our common stock at a price below net asset value, please

see the table below under the heading “Examples of Dilutive Effect of the Issuance of Shares Below Net Asset

Value.”

Finally, any sale of substantial amounts of the Company’s common stock or other securities in the open market may

adversely affect the market price of the Company’s common stock and may adversely affect the Company’s ability

to obtain future financing in the capital markets. In addition, future sales of the Company’s common stock to the

public may create a potential market overhang, which is the existence of a large block of shares readily available for

sale that could lead the market to discount the value of shares held by other investors. In the event the Company

were to continue to sell its common stock at prices below net value for sustained periods of time, such offerings may

result in sustained discounts in the marketplace.

Examples of Dilutive Effect of the Issuance of Shares Below Net Asset Value

The table on the following page illustrates the level of net asset value dilution that would be experienced by a

nonparticipating stockholder in four different hypothetical offerings of different sizes and levels of discount from net

asset value per share, although it is not possible to predict the level of market price decline that may occur. Actual

sales prices and discounts may differ from the presentation below.

The examples assume that Company XYZ has 1,000,000 shares of common stock outstanding, $15,000,000 in total

assets and $5,000,000 in total liabilities. The current net asset value and net asset value per share are thus

$10,000,000 and $10.00. The table illustrates the dilutive effect on nonparticipating Stockholder A of (1) an offering

of 50,000 shares (5% of the outstanding shares) at $9.50 per share after offering expenses and commission (a 5%

discount from net asset value), (2) an offering of 100,000 shares (10% of the outstanding shares) at $9.00 per share

after offering expenses and commissions (a 10% discount from net asset value), (3) an offering of 200,000 shares

(20% of the outstanding shares) at $8.00 per share after offering expenses and commissions (a 20% discount from

net asset value) and (4) an offering of 250,000 shares (25% of the outstanding shares) at $0.01 per share after

offering expenses and commissions (a 100% discount from net asset value). Because we are not limited as to the

amount of discount from net asset value at which we can offer shares, the fourth example on the following table (an

offering at a price of $0.01 per share) is included, however, the Company will not offer shares at a 100% discount to

net asset value. “NAV” in the table below stands for “net asset value.”

Dilutive Effect of the Issuance of Shares by Company XYZ Below Net Asset Value


		Example 1 5% Offering at 5% Discount		Example 2 10% Offering at 10% Discount		Example 3 20% Offering at 20% Discount		Example 4 25% Offering at 100% Discount
	Prior to Sale Below NAV	Following Sale	% Change	Following Sale	% Change	Following Sale	% Change	Following Sale	% Change
Offering Price
Price per Share to Public ...........................	—	$10.00	—	$9.47	—	$8.42	—	$0.01	—
Net Proceeds per Share to Issuer .......................	—	$9.50	—	$9.00	—	$8.00	—	$0.01	—
Decrease to NAV
Total Shares Outstanding .................	1,000,000	1,050,000	5.00%	1,100,000	10.00%	1,200,000	20.00%	1,250,000	25.00%
NAV per Share ............	$10.00	$9.98	(0.24)%	$9.91	(0.91)%	$9.67	(3.33)%	$8.00	(19.98)%
Dilution to Stockholder
Shares Held by Stockholder A ..............	10,000	10,000	—	10,000	—	10,000	—	10,000	—
Percentage Held by Stockholder A ..............	1.0%	0.95%	(4.76)%	0.91%	(9.09)%	0.83%	(16.67)%	0.80%	(20.00)%
Total Asset Values
Total NAV Held by Stockholder A ..............	$100,000	$99,762	(0.24)%	$99,091	(0.91)%	$96,667	(3.33)%	$80,020	(19.98)%
Total Investment by Stockholder A (Assumed to Be $10.00 per Share) ........	$100,000	$100,000	—	$100,000	—	$100,000	—	$100,000	—
Total Dilution to Stockholder A (Total NAV Less Total Investment) ..................	—	$(238)	—	$(909)	—	$(3,333)	—	$(19,980)	—
Per Share Amounts
NAV per Share Held by Stockholder A .........	—	$9.98	—	$9.91	—	$9.67	—	$8.00	—
Investment per Share Held by Stockholder A (Assumed to be $10.00 per Share on Shares Held Prior to Sale) .......	$10.00	$10.00	—	$10.00	—	$10.00	—	$10.00	—
Dilution per Share Held by Stockholder A (NAV per Share Less Investment per Share) ..	—	$(0.02)	—	$(0.09)	—	$(0.33)	—	$(2.00)	—
Percentage Dilution to Stockholder A (Dilution per Share Divided by Investment per Share) ....................	—	—	(0.24)%	—	(0.91)%	—	(3.33)%	—	(19.98)%

The Board of Directors recommends a vote “FOR” the proposal to authorize the Company, with the subsequent

approval of its Board of Directors, to issue and sell shares of its common stock (during the 12 months following

such authorization) at a price below its then-current net asset value per share in one or more offerings, subject to

certain limitations set forth herein (including, without limitation, that the number of shares issued and sold

pursuant to such authority does not exceed 30% of the Company’s then-outstanding common stock immediately

prior to each such offering).

Required Vote.

Approval of this proposal requires the affirmative vote of each of the following: (1) a majority of the outstanding

shares of the Company's common stock; and (2) a majority of the outstanding shares of the Company's common

stock that are not held by affiliated persons of the Company. For purposes of this proposal, the 1940 Act defines a

"majority of the outstanding shares” as the vote of the lesser of: (1) 67% or more of the voting securities of the

Company present at the Annual Meeting if the holders of more than 50% of the outstanding voting securities of the

Company are present virtually or represented by proxy; or (2) more than 50% of the outstanding voting securities of

the Company. Abstentions and broker non-votes, if any, will have the effect of votes cast against this proposal.

ADDITIONAL INFORMATION

The Notice of Annual Meeting, this proxy statement and our annual report for the fiscal year ended December 31,

2024 are available free of charge at the following Internet address: https://ir.barings.com/annual-shareholder-

meeting-materials.

STOCKHOLDER NOMINATIONS AND PROPOSALS FOR THE 2026 ANNUAL MEETING

The Company's annual meeting of stockholders generally is held in May of each year. We will consider for inclusion

in the Company's proxy materials for the 2026 Annual Meeting of Stockholders, stockholder proposals that are

received at the Company's executive offices, in writing, no later than 5:00 p.m. (Eastern Time) on November 11,

2025, and that comply with all applicable requirements of Rule 14a-8 promulgated under the Securities Exchange

Act of 1934, as amended, or the Exchange Act.

In addition, any stockholder who wishes to propose a nominee to the Board of Directors or propose any other

business to be considered by the stockholders (other than a stockholder proposal to be included in the Company’s

proxy materials pursuant to Rule 14a-8 of the Exchange Act) must comply with the advance notice provisions and

other requirements of the Company’s Bylaws, a copy of which is on file with the SEC and may be obtained from the

Company’s Secretary upon request. Proposals must be sent to the Company’s Secretary at Barings BDC, Inc., 300

South Tryon Street, Suite 2500, Charlotte, North Carolina 28202. These notice provisions require that nominations

of persons for election to the Board of Directors and proposals of business to be considered by the stockholders for

the 2026 Annual Meeting of Stockholders must be made in writing and submitted to the Company’s Secretary at the

address above no earlier than November 11, 2025 and no later than 5:00 p.m. (Eastern Time) on December 11, 2025

and must otherwise be a proper action by the stockholders. We advise you to review the Bylaws, which contain

additional information and other requirements about advance notice of stockholder proposals and director

nominations, including the different notice submission date requirements in the event that the Company’s 2026

Annual Meeting of Stockholders is held before April 8, 2026 or after June 7, 2026. In accordance with the Bylaws,

the chairman of the 2026 Annual Meeting of Stockholders may determine, if the facts warrant, that a matter has not

been properly brought before the meeting and, therefore, may not be considered at the meeting.

FINANCIAL STATEMENTS AVAILABLE

A letter to stockholders and a copy of the Company's Annual Report on Form 10-K for the fiscal year ended

December 31, 2024, which together constitute the Company's 2024 Annual Report, are being mailed along with this

proxy statement. The Company's 2024 Annual Report is not incorporated into this proxy statement and shall not be

considered proxy solicitation material.

We will also mail to you without charge, upon written request, a copy of any specifically requested exhibit to

the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024. Requests should be

sent to: Barings BDC, Inc. Investor Relations, 300 South Tryon Street, Suite 2500, Charlotte, North Carolina 28202,

or such requests may be made by calling (704) 805-7200. A copy of the Company's Annual Report on Form 10-K

has also been filed with the SEC and may be accessed through the SEC’s homepage (http://www.sec.gov).

HOUSEHOLDING OF PROXY MATERIALS

The SEC has adopted rules that permit companies and intermediaries, such as brokers, to satisfy the delivery

requirements for proxy statements and annual reports with respect to two or more stockholders sharing the same

address by delivering a single proxy statement addressed to those stockholders. This process, which is commonly

referred to as “householding,” potentially provides extra convenience for stockholders and cost savings for

companies.

Brokers may be householding the Company's proxy materials by delivering a single proxy statement and 2024

Annual Report to multiple stockholders sharing an address, unless contrary instructions have been received from the

affected stockholders. Once you have received notice from your broker that they will be householding materials to

your address, householding will continue until you are notified otherwise or until you revoke your consent. If you

did not respond that you did not want to participate in householding, you were deemed to have consented to the

process. If at any time you no longer wish to participate in householding and would prefer to receive a separate

proxy statement and Annual Report, or if you are receiving multiple copies of the proxy statement and 2024 Annual

Report and wish to receive only one, please notify your broker if your shares are held in a brokerage account, or us if

you are a stockholder of record. You can notify us by sending a written request to: Barings BDC, Inc. Investor

Relations, 300 South Tryon Street, Suite 2500, Charlotte, North Carolina 28202, or by calling (888) 401-1088. In

addition, we will promptly deliver, upon written or oral request to the address or telephone number above, a separate

copy of the 2024 Annual Report and proxy statement to a stockholder at a shared address to which a single copy of

the documents was delivered.

TABULATION AND REPORTING OF VOTING RESULTS

Preliminary voting results will be announced at the Annual Meeting. Final voting results will be tallied by the

inspector of election after the taking of the vote at the Annual Meeting. The Company will publish the final voting

results in a Current Report on Form 8-K filed with the SEC within four business days following the Annual Meeting.

OTHER INQUIRIES

If you have any questions about the Annual Meeting, these proxy materials or your ownership of the Company's

common stock, please contact Barings BDC, Inc. Investor Relations, 300 South Tryon Street, Suite 2500, Charlotte,

North Carolina 28202, Telephone: (704) 805-7200.

OTHER BUSINESS

The Board of Directors knows of no other business to be presented for action at the 2025 Annual Meeting of

Stockholders. If, however, any other matters do come before the meeting on which action can properly be taken, it is

the intention of the persons named on the enclosed proxy card to vote on such matters in accordance with their

judgment. The submission of a proposal does not guarantee its inclusion in the Company's proxy statement or

presentation at the meeting unless certain requirements under applicable securities laws and the Company's Bylaws

are met.

You are cordially invited to attend the 2025 Annual Meeting of Stockholders of Barings BDC, Inc., to be held

virtually on Thursday, May 8, 2025, at 8:30 a.m. (Eastern Time), at the following website:

www.virtualshareholdermeeting.com/BBDC2025. Your vote is important and, whether or not you plan to

attend the meeting, you are requested to complete, date, sign and promptly return the accompanying proxy

card in the enclosed postage-paid envelope.

By order of the Board of Directors,

Alexandra Pacini

Secretary, Barings BDC, Inc.

Charlotte, North Carolina

March 11, 2025

Insider Trading Policies and Procedures	12 Months Ended
Insider Trading Policies and Procedures	Dec. 31, 2024
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted	true

N-2 - $ / shares

3 Months Ended

12 Months Ended

Dec. 31, 2024

Sep. 30, 2024

Jun. 30, 2024

Mar. 31, 2024

Dec. 31, 2023

Sep. 30, 2023

Jun. 30, 2023

Mar. 31, 2023

Dec. 31, 2022

Sep. 30, 2022

Jun. 30, 2022

Mar. 31, 2022

Dec. 31, 2024

Cover [Abstract]

Entity Central Index Key

0001379785

Amendment Flag

false

Document Type

DEF 14A

Entity Registrant Name

Barings BDC, Inc.

General Description of Registrant [Abstract]

Share Price [Table Text Block]


	Net Asset Value	Closing Sales Price		Premium (Discount) of High Closing Sales Price to Net Asset Value	Premium (Discount) of Low Closing Sales Price to Net Asset Value
	Net Asset Value	High	Low
Year ended December 31, 2022
First Quarter ..............................................	$11.86	$11.20	$10.07	(5.6)%	(15.1)%
Second Quarter ..........................................	$11.41	$10.90	$9.24	(4.5)%	(19.0)%
Third Quarter .............................................	$11.28	$10.41	$8.32	(7.7)%	(26.2)%
Fourth Quarter	$11.05	$9.26	$8.06	(16.2)%	(27.1)%
Year ended December 31, 2023
First Quarter ..............................................	$11.17	$8.95	$8.22	(19.9)%	(26.4)%
Second Quarter ..........................................	$11.34	$8.01	$7.19	(29.4)%	(36.6)%
Third Quarter .............................................	$11.25	$9.34	$7.65	(17.0)%	(32.0)%
Fourth Quarter ...........................................	$11.28	$9.39	$8.58	(16.8)%	(23.9)%
Year ended December 31, 2024
First Quarter ..............................................	$11.44	$9.88	$8.70	(13.6)%	(24.0)%
Second Quarter ..........................................	$11.36	$10.18	$9.13	(10.4)%	(19.6)%
Third Quarter .............................................	$11.32	$10.19	$9.28	(10.0)%	(18.0)%
Fourth Quarter ...........................................	$11.29	$10.33	$9.27	(8.5)%	(17.9)%
Year ending December 31, 2025 ..............
First Quarter (Through March 7, 2025) ....	*	$10.78	$9.36	*	*

* Net asset value has not yet been calculated for this period.

Lowest Price or Bid

$ 9.27

$ 9.28

$ 9.13

$ 8.70

$ 8.58

$ 7.65

$ 7.19

$ 8.22

$ 8.06

$ 8.32

$ 9.24

$ 10.07

Highest Price or Bid

$ 10.33

$ 10.19

$ 10.18

$ 9.88

$ 9.39

$ 9.34

$ 8.01

$ 8.95

$ 9.26

$ 10.41

$ 10.90

$ 11.20

Highest Price or Bid, Premium (Discount) to NAV [Percent]

(8.50%)

(10.00%)

(10.40%)

(13.60%)

(16.80%)

(17.00%)

(29.40%)

(19.90%)

(16.20%)

(7.70%)

(4.50%)

(5.60%)

Lowest Price or Bid, Premium (Discount) to NAV [Percent]

(17.90%)

(18.00%)

(19.60%)

(24.00%)

(23.90%)

(32.00%)

(36.60%)

(26.40%)

(27.10%)

(26.20%)

(19.00%)

(15.10%)

NAV Per Share

$ 11.29

$ 11.32

$ 11.36

$ 11.44

$ 11.28

$ 11.25

$ 11.34

$ 11.17

$ 11.05

$ 11.28

$ 11.41

$ 11.86

$ 11.29

Capital Stock, Long-Term Debt, and Other Securities [Abstract]

Security Voting Rights [Text Block]

VOTING SECURITIES

You may vote at the Annual Meeting only if you were a holder of record of the Company's common stock at the

close of business on March 7, 2025 or if you hold a valid proxy from a stockholder of record as of such record date.

As of March 7, 2025, there were 105,408,938 shares of the Company's common stock outstanding. Each share of

common stock is entitled to one vote on each matter submitted to a vote at the Annual Meeting. Stockholders do not

have the right to cumulate votes in the election of directors.

Long Term Debt [Table Text Block]